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ABSTRACT 
Acute lung injury is marked by profound neutrophil influx along with fluid 
accumulation that impairs lung function at the cost of high mortality (up to 40%). Neutrophils 
are activated and their constitutive apoptosis is inhibited during this phase in order to be 
competent phagocytes over the next few hours. Activated neutrophils release copious 
amounts of toxic mediators that cause tissue damage leading to impaired barrier function and 
finally, impaired lung function. Therefore, one of the critical needs is to identify molecules 
that regulate neutrophil migration and silence activated neutrophils to prevent exuberant 
tissue damage. Angiostatin is an anti-angiogenic molecule highly expressed in lavage fluid of 
patients with acute respiratory distress syndrome. Angiostatin has recently been shown to 
inhibit neutrophil infiltration in mice peritonitis. However, the role of angiostatin in 
modulating neutrophil physiology and lung inflammation remains unknown.  
I studied the role of angiostatin, an anti-angiogenic molecule, in neutrophil activation 
and recruitment in vivo and in vitro. Angiostatin was endocytosed only by activated 
neutrophils, inhibited neutrophil polarity in fMLP-activated neutrophils probably through 
integrin αVβ3, and inhibited MAPK signalling in LPS-activated neutrophils. Angiostatin 
suppressed formation of reactive oxygen species and activated caspase-3 in neutrophils in 
both pre-and post-LPS treatments.  Finally, angiostatin reduced adhesion and emigration of 
neutrophils in post-capillary venules of TNF-treated cremaster muscle.  
The next study was designed to investigate the role of angiostatin in acute lung injury. 
I used E. coli lipopolysaccharide induced acute lung injury mouse model to test the effects of 
angiostatin through analyses of bronchoalveolar lavage and lung tissues. In addition, I made 
novel use of synchrotron diffraction enhanced imaging of mouse lungs to assess lung area and 
iii 
contrast ratios over 9 hours as surrogates for lung inflammation. Subcutaneous treatment with 
angiostatin reduced neutrophil influx, protein accumulation, lung Gr1+ neutrophils and 
myeloperoxidase activity, phosphorylated p38 MAPK without affecting the levels of MIP-1α, 
IL-1β, KC and MCP-1 in lavage and lung homogenates. Diffraction enhanced imaging 
showed that angiostatin causes a time-dependent improvement in lung area and lung contrast 
ratios that reflect improvement in lung edema. Overall, the study shows that angiostatin is a 
novel inhibitor of acute lung injury in mice. Moreover, DEI offers a highly useful technique 
in evaluating dynamics of lung inflammation and to investigate the therapeutic impact of new 
drugs on lung inflammation. 
I conclude that angiostatin is a novel inhibitor of neutrophil migration, activation and 
acute lung injury. 
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CHAPTER 1 
REVIEW OF LITERATURE 
1.1. Acute Lung Injury 
Localized pathologic changes in acute inflammation have been reported since more than 
2000 years ago by Cornelius Celsus as “rubor et tumor cum calore et dalore” meaning “redness 
and swelling with heat and pain”. Rudolph Virchow extended this definition by “loss of 
function” (“functio laesa”) observed in more severe inflammation. Julius Cohnheim explained 
these observations in frog tongue under a microscope for the first time. The redness and heat 
reflect an increased blood flow; the swelling is due to exudation of fluid and cell accumulation 
and pain follows. Elie Metchnikoff concluded that inflammation is a local reaction produced by 
phagocytic activity of leukocytes and a chemical reaction, now recognized as production of 
various mediators, of blood plasma and tissue fluids (Plytycz, Seljelid 2003). Most of the times, 
acute inflammation is beneficial and resolves after some time. In an event of severe infection or 
insult, it can progress to chronic inflammation. 
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are medical 
emergency conditions with reported mortality of up to 40% resulting from a wide array of 
diseases, both infectious and non-infectious, like pneumonia, influenza, acid aspiration, sepsis, 
pancreatitis and transfusion-related ALI (Grommes, Soehnlein 2011, Jain, Bellingan 2007). 
While most of the above mentioned diseases cause direct lung damage, the last two are indirect 
causes, which lead to systemic inflammatory response syndrome that further causes ALI/ARDS. 
ALI is a less severe form of sepsis whereas ARDS manifests as multiple organ dysfunction in all 
instances. ALI is characterized by increased permeability of alveolar-capillary barrier resulting in 
lung edema and protein exudation leading to impaired blood oxygenation. Neutrophil activation 
and accumulation in the interstitium and bronchoalveolar space is a hallmark of ALI/ARDS. 
Although neutrophils are components of the host innate immune mechanism, activated 
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neutrophils live longer and they cause tissue damage through their inflammatory products such 
as proteinases, cationic polypeptides, cytokines and reactive oxygen species (ROS) (Witko-
Sarsat, Rieu et al. 2000, Dallegri, Ottonello 1997, Haslett 1999, Haslett, Savill et al. 1989). In 
ARDS patients, neutrophil numbers in bronchoalveolar lavage fluid (BAL) correlate with ARDS 
severity and outcome (Parsons, Fowler et al. 1985, Matthay, Eschenbacher et al. 1984). 
Moreover, mice models of ALI show improvement upon neutrophil depletion (Abraham, 
Carmody et al. 2000) or by inhibiting neutrophil chemokine, IL-8 in rabbits (Folkesson, Matthay 
et al. 1995). However, it must also be noted that neutrophil transmigration can occur without 
endothelial damage (Martin, Pistorese et al. 1989). Neutropenic children can develop ALI/ARDS 
indicating the presence of neutrophil-independent mechanisms (Laufe, Simon et al. 1986, 
Ognibene, Martin et al. 1986, Sivan, Mor et al. 1990). A majority of literature, however, 
highlights key role of neutrophils in the progression of ALI/ARDS. Therefore, it is important to 
modulate neutrophil activation and transmigration to attenuate the deleterious tissue effects while 
preserving their anti-bacterial function. Below is a detailed account of sub-cellular events 
controlling the directional movement of neutrophils towards site of injury called chemotaxis. 
1.1.1. Neutrophil Chemotaxis 
Cells are programmed and equipped to migrate. There are two major kinds of cell 
movements, single cell (amaeboid and mesenchymal or haptokinetic) and collective (cell sheets, 
strands, tubes, clusters) migration modes. Collective migration involves maintenance of cell-cell 
junctions and communication as observed in vascular sprouts, invading epithelial strands or 
tubes and tumor clusters. Based on the focus of this research project, a detailed discussion of 
collective cell migrations is beyond the scope of this review. Mesenchymal or the haptokinetic 
cells such as fibroblasts, endothelial cells, myoblasts or sarcoma cells, form spindle shaped 
morphology and establish firm integrin-mediated contacts with substrate as well as high traction 
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at both cell poles resulting in very low migration velocities of 0.1-2 µm/min (Friedl, Borgmann 
et al. 2001). Among single cell movements, amoeboid are the most primitive form of highly 
mobile single cell movements. Leukocytes fall under this category as they undergo rapid 
morphological changes while establishing minimal or nascent contacts with substrate. This 
property of deformability enables rapid migration velocities of 2-30 µm/min (Friedl, Borgmann 
et al. 2001). Cortical filamentous actin mediates cell dynamics but mature focal contacts and 
stress fibers are lacking. Chemotaxis is the directional movement of such specialized immune 
cells towards specific chemoattractant molecules enabling these cells to efficiently reach the site 
of inflammation, howsever small it may be, in the shortest possible time. Neutrophils (PMNs) 
are a seminal cell population found at acute inflammation sites. This is afforded by property of 
chemotaxis. In fact, PMNs can respond to as low as 1/100
th
 of chemoattractant gradients and yet 
prioritize their migration towards bacterial peptides over a multitude of other chemoattractants to 
finally reach the site of inflammation (Insall 2010). Neutrophils adopt the eukaryotic chemotaxis 
model, known as the pseudopod-centered model, in which random pseudopods are generated in 
the presence of very shallow chemoattractant gradients that enable swift directional changes 
while moving randomly (Insall 2010, Insall, Machesky 2009). A comprehensive review of 
biology of these events is provided in the next couple of paragraphs. 
1.1.1.1. Actin Dynamics 
 Neutrophils respond to chemoattractants by formation of ruffles all over the cell body, 
accompanied by a two to three fold transient rise in polymerized cortical F-actin in the ruffles. A 
minute later their shape changes with contracted tail in the rear and F-actin rich ruffles in the 
front (Campellone, Welch 2010, Niggli 2003) (Figure 1). The process of actin polymerization is 
dynamic due to requirement of continual tail de-adhesion and leading edge formation in order for  
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Figure 1a: Neutrophil actin stained with rhodamine phalloidin (in red), nucleus stained with 
DAPI (in blue) in response to 100nM formyl-methionyl-leucyl-phenylalanine, fMLP. Neutrophil 
leading edge shows membrane ruffles rich in polymerized F-actin (depicted by white arrow) and 
rear tail (depicted by green arrow head).  
Figure 1b: A schematic representation of GTPase molecular switch showing GTP recycling by 
two enzymes GTPase activating protein (GAP) and Gunanine nucleotide exchange factor (GEF). 
At the time these events are occurring at the leading edge, the rear tail of the cell also undergoes 
cytoskeletal microtubule destabilization (Eddy, Pierini et al. 2002, Ehrengruber, Deranleau et al. 
1996). This occurs by small heat shock protein-27 (hsp-27) phosphorylation (Jog, Jala et al. 
2007).
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neutrophils to roll on endothelial cells or in the interstitium. Chemoattractants such as IL-8, 
formyl-methionyl-leucyl-phenylalanine (fMLP) couple to βγ subunits of G proteins that signal 
through GTP bound small GTPases like Rho, Rac and cdc-42 (Szczur, Zheng et al. 2009, Szczur, 
Zheng et al. 2009, Hall 1992, Hall 1992, Geiszt, Dagher et al. 1998, Lad, Olson et al. 1985). 
Small G-proteins require continual recycling of guanine nucleotide triphosphate (GTP) to 
guanine nucleotide diphosphate (GDP) and inorganic phosphate. GDP pools are bound to a 
protein called GDP Dissociation Inhibitor which is facilitated by enzymes such as GTPase 
activating proteins (GAPs) like p190 Rho GAP and guanine nucleotide exchange factors (GEFs) 
like DOCK2, VAV1, VAV3 (Niggli 2003,  Matsumoto, Molski et al. 1987). Figure 1b describes 
a schematic of the GTPase molecular switch. 
1.1.2. In vivo Neutrophil Recruitment 
 Intravascular immunity had long been ignored due to lack of technical advances in in vivo 
imaging. Intravital microscopy provides the required high spatio-temporal resolution for tracking 
directed leukocyte migration. In the past decade, fluorescent spinning disk intravital imaging has 
enabled new insight into immune cell recruitment. But tracking of all leukocyte subsets has not 
been possible due to lack of lineage-specific markers. Genetic engineering of green fluorescent 
protein (GFP) tagged leukocyte subsets has, however, enabled visualization of patrolling 
monocytes and neutrophil migration behaviors in CX3CR1
gfp/gfp
 mice (Auffray, Fogg et al. 
2007). Recently, a group has shown monocyte dependent neutrophil extravasation in mice lungs 
by utilizing two-photon microscopy (Kreisel, Nava et al. 2010).  
1.1.2.1. Intravital Microscopy of Cremaster Tissue. Simple vascular beds of tissues 
such as mesentery and cremaster muscle are easily visualized upon transillumination and 
with minimal preparation-induced inflammation.  In contrast, it is a major technical 
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challenge to image complex vascular system of organs such as the lung and liver. 
Therefore, cremaster muscle has been extensively used to elucidate the basic mechanisms 
of leukocyte recruitment. Although it is extremely difficult to eliminate basal rolling due 
to surgical trauma, the basal adhesion and emigration should be near zero values. The 
anesthetized mouse is placed on a board that has circulating warm water running through 
a milled internal cavity (Figure 2). An incision is made in the scrotal skin to expose the 
left cremaster muscle, which is carefully removed from the associated fascia. A 
lengthwise incision is made on the ventral surface of the cremaster muscle using a 
cautery. The testicle and the epididymis is separated from the underlying muscle and 
moved into the abdominal cavity. The muscle is then spread out over an optically clear 
viewing pedestal and secured along the edges with threads. The exposed tissue is 
superfused with warm bicarbonate-buffered saline.  
1.1.2.2. Evaluation of leukocyte recruitment. The number of rolling, adherent, and 
emigrated leukocytes is determined off-line during video playback analysis. Rolling 
leukocytes are defined as those cells moving at a velocity less than that of erythrocytes 
within a given vessel. The flux of rolling cells is measured as the number of rolling cells 
passing by a given point in the venule per minute. A leukocyte is considered to be 
adherent if it remained stationary for at least 30 s, and total leukocyte adhesion is 
quantified as the number of adherent cells within a 100 μm length of a venule. Leukocyte 
emigration is defined as the number of cells in the extravascular space within a 200 × 300 
μm area. Only cells adjacent to and clearly outside the vessel under study are counted as 
emigrated. The experiment is videotaped in real-time. Numerous parameters are generally 
recorded as indicated in (Table 1). 
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Figure 2: Intravital set-up and design of cremaster board with warm circulating water (Modified 
from Cara and Kubes, 2003) 
Table 1: Parameters recorded off-line from intravital microscopy recording.
Time 
Point 
Video 
(Start) 
Rec.(Day) 
Start 
Rec.(Day) 
Stop 
Diameter 
(m) 
Velocity 
RBC 
FLUX 
(cells/min) 
ADHESION 
(cells/5min) 
Emigration 
(cells) 
WBC 
sec/100 
m 
(first 20 
cells) 
Velocity 
WBC 
(µM/sec) 
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Immune cells undergo a series of sequential steps during extravasation from blood 
vessels to tissues. These include tethering, rolling, crawling, and transmigration (Ley, 
Laudanna et al. 2007, Liu, Kubes 2003) (Figure 3a).             
1.1.2.3. Rolling. The family of selectin adhesion molecules, especially P-selectin and E-
selectin, expressed by endothelial cells facilitate initial tethering and rolling of 
neutrophils in post-capillary venules of peripheral vasculature. In lungs, selectin blockade 
is unable to reduce leukocyte recruitment in some but not all forms of inflammation 
(Doerschuk, Quinlan et al. 1996, Mizgerd, Meek et al. 1996). In lungs, leukocyte 
adhesion occurs in capillaries without requirement of rolling, also termed as 
“sequestration” (Selby, MacNee 1993). Although physical trapping of leukocytes could 
afford one reason, there is no conclusive evidence and there could be other adhesion 
molecules involved in lung (Figure 3b). Constitutive rolling in non-inflamed tissues such 
as skin is due to constitutive expression of E- and P-selectin (Weninger, Ulfman et al. 
2000). As skin is constantly exposed to external environment, constitutive rolling is a 
sentinel mechanism by which leukocytes patrol the vascular endothelium to detect any 
infection. Studies in which tissues are surgically exteriorized show P-selectin dependent 
rolling in non-inflamed tissues but this has been attributed as a response to surgery 
(Kubes, Kanwar 1994). Therefore, it is not known whether constitutive rolling is seen in 
non-inflamed tissues in peripheral vascular beds, lungs and intestine. Neutrophil transit 
time is extended in lungs suggesting retention in pulmonary vasculature (Selby, MacNee 
1993, Hogg, Doerschuk et al. 1992, Doerschuk, Downey et al. 1990, Doerschuk, Allard 
et al. 1987). 
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Figure 3a: A schematic showing the major steps of neutrophil migration in a peripheral post-
capillary venule in response to injury namely tethering, rolling, crawling, and transmigration. 
Neutrophils typically migrate from venules in response to injury. Neutrophil migration begins 
through the formation of selectin-mediated nascent contacts with the endothelium followed by 
firm adhesion induced by integrins and finally transmigration across the endothelium towards 
injury site. 
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Figure 3b: A schematic showing neutrophil migration in a lung capillaries in response to injury. 
Neutrophil migration in the lungs defies this paradigm for many reasons. First, narrow diameter 
and tortuous nature of the lung capillaries results in retention of large number of neutrophils. 
Second, pulmonary vasculature is a low blood pressure zone compared to the peripheral 
vasculature. Finally, the recruitment appears to be independent of selectins and β2 integrins. 
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1.1.2.4. Crawling. Adhesion to the endothelium occurs through α4 and β2 integrins after 
chemokine presentation on the surface of endothelium following extravascular damage 
and/or infection. Ligand-induced integrin clustering and allosteric conformational 
changes probably initiate outside-in signalling and the formation of signalosomes, which 
are required for recruitment of protein tyrosine kinases (PTKs) (Liu, Kiosses et al. 2002). 
FGR and HCK (haemopoeitic cell kinase), two src-like PTKs that are crucial transducers 
of outside-in signalling by LFA1 and MAC1, are not required for chemoattractant-
triggered upregulation of LFA1 affinity (inside-out signalling) and rapid neutrophil 
adhesion under flow (Giagulli, Ottoboni et al. 2006). However, the lack of 2-integrin 
outside-in signalling accelerates the detachment of adherent neutrophils under flow. 
Neutrophils lacking the GEFs VAV1 and VAV3 (Martinez Gakidis, Cullere et al. 2004) 
or PI3Kγ (Smith, Deem et al. 2006) also detach easily. These “hot spots” for adhesion 
mediated via lymphocyte function-associated antigen 1 (LFA1 also known as αLβ2 
integrin) on neutrophils are often not the final sites of extravasation. The adherent 
neutrophils often crawl, not necessarily in the direction of flow, to junctions and finally 
emigrate out of the vasculature (Phillipson, Heit et al. 2006).  Inhibition of crawling 
delays but does not inhibit emigration in-vivo. However, in-vitro monocytes’ crawling 
has been shown to be an essential step for diapedesis (Schenkel, Mamdouh et al. 2004).  
1.1.2.5. Transmigration. The site of neutrophil emigration is not well defined. Most of 
the studies indicate that neutrophils migrate at inter-endothelial junctions (paracellular 
route) (Phillipson, Heit et al. 2006, Schenkel, Mamdouh et al. 2004). There is some 
evidence of migration of neutrophils through endothelial cells too (transcellular route) 
(Ley, Laudanna et al. 2007, Kamei, Carman 2010, Carman, Springer 2004, Feng, Nagy et 
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al. 1998). Molecular mechanisms of transmigration are even less understood than the site 
of emigration. There are reports of involvement of platelet/endothelial cell adhesion 
molecule (PECAM; also known as CD31), junctional adhesion molecules (JAMs), CD99, 
endothelial cell adhesion molecule 1 (ECAM1) and possibly intercellular adhesion 
molecules (ICAMs) and integrins (Ley, Laudanna et al. 2007, Muller 2009). Extension of 
leukocyte membrane protrusions into the endothelial-cell body and endothelial-cell 
junctions is triggered by ligation of intercellular adhesion molecule 1 (ICAM1) by MAC1 
(macrophage antigen 1) (Phillipson, Heit et al. 2006, Schenkel, Mamdouh et al. 2004). 
Ligation of ICAM1 is associated with increased intracellular Ca
2+
 and activation of p38 
mitogen-activated protein kinase (MAPK) and RAS homologue (Rho) GTPase, which 
may collectively activate myosin light-chain kinase leading to enhanced endothelial-cell 
contraction and hence opening of interendothelial contacts. Leukocyte migraton through 
endothelial cell barrier is rapid (<2-5 minutes) but penetration of endothelial cell 
basement membrane is slower (>5-15 minutes) (Ley, Laudanna et al. 2007). 
Transmigration can by triggered by luminal chemoattractants along with shear flow 
(Cinamon, Shinder et al. 2004). As  indicated earlier, adherent leukocytes can induce 
formation of “docking structures” or “transmigratory cups” or “endothelial domes” which 
are endothelial cell projections rich in leukocyte-specific protein 1 (LSP-1), ICAM1 and 
VCAM1 and cytoplasmic molecules such as ezrin, radixin and moesin proteins and 
cytoskeletal components (such as vinculin, α-actinin and talin-1) (Kamei, Carman 2010, 
Carman, Springer 2004, Petri, Kaur et al. 2011, Riethmuller, Nasdala et al. 2008). Such 
endothelial domes are an efficient way of providing a protective barrier against excessive 
plasma and protein loss as evidenced in LSP1
-/-
 mice (Petri, Kaur et al. 2011). 
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1.1.2.6. Paracellular migration involves the release of endothelial-expressed vascular 
endothelial cadherin (VE-cadherin) and is facilitated by intracellular membrane 
compartments containing a pool of platelet/endothelial-cell adhesion molecule 1 
(PECAM1) and possibly other endothelial-cell junctional molecules, such as junctional 
adhesion molecule A (JAM-A). Other molecules involved in paracellular transmigration 
are endothelial cell-selective adhesion molecule (ESAM), ICAM2 and CD99. 
1.1.2.7. Transcellular migration occurs in ‘thin’ parts of endothelial cells, which create a 
shorter distance for a leukocyte to migrate (Feng, Nagy et al. 1998). ICAM1 ligation 
leads to translocation of ICAM1 to actin- and caveolae-rich regions. ICAM1-containing 
caveolae link together forming vesiculo-vacuolar organelles (VVOs) creating an 
intracellular passage for the leukocyte migration. Ezrin, radixin and moesin proteins 
could act as linkers between ICAM1 and cytoskeletal proteins (such as actin and 
vimentin), causing their localization around the channel, thereby providing structural 
support for the cell under these conditions (Kamei, Carman 2010, Carman, Springer 
2004, Barreiro, De La Fuente et al. 2007, Barreiro, Yáñez-Mó et al. 2002).  
1.1.2.8. Migration through the endothelial basement membrane and pericyte sheath. 
This can occur through gaps between adjacent pericytes and regions of low protein 
deposition within the extracellular matrix. This response can be facilitated by α6β1-
integrin and possibly proteases, such as matrix metalloproteinases (MMPs) and 
neutrophil elastase (NE) (Ley, Laudanna et al. 2007, Vestweber 2007). 
To sum up, the prevailing mode of migration is considered to be “haptokinetic” (Friedl, 
Borgmann et al. 2001), that is, a migrating cell follows adhesion predetermined paths. Specificity 
and diversity is attributed firstly to eight subunits assorting to 18 subunits forming 24 distinct 
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integrins, and secondly to various matrix metalloproteinases (MMPs) degrading the extracellular 
matrix (ECM). How all cell types fit into this model and still be adequately regulated in response 
to an acute immune attack or for maintaining overall homeostasis is not well understood. A 
recent study has elegantly shown that in pan-integrin deficient mice, rapidly migrating cells such 
as neutrophils and dendritic cells do not follow this haptokinetic mode. In contrast to two-
dimensional intravascular migration, the migration through three dimensional ECM was shown 
to be integrin but not protrusion independent (Lammermann, Bader et al. 2008). The authors 
proposed a “flowing and squeezing” model whereby protrusion drives basal locomotion and 
actin-myosin mediated trailing edge contraction propels the nucleus of migrating cell that is 
functionally dissociated into a front and back. There is no digestion and remodelling, hence 
avoiding collateral tissue damage. 
1.1.3. Chemotaxis Signaling Pathways 
Numerous downstream signaling pathways are activated after chemoattractant ligation to 
heterotrimeric G proteins (Campellone, Welch 2010, Niggli 2003). The lipid phosphatidyl 
inositol 4,5-biphosphate [PtIns(4,5)P2] can be hydrolyzed by phospholipase C to diacylglycerol 
that activates protein kinase C (PKC) isoforms and inositol 1,4,5-triphosphate that activates 
intracellular calcium release. [PtIns(4,5)P2] can also be hydrolyzed by phosphoinositide 3-kinase 
(PI 3K) into phosphatidyl inositol 3,4,5-triphosphate [PtIns(3,4,5)P3] (also commonly called 
PIP3) and phosphatidyl inositol 3,4-biphosphate [PtIns(3,4)P2] (Stephens, Ellson et al. 2002). 
Mitogen activated protein kinases (MAPK) and phosphatases are activated downstream of Rho 
family of GTP binding small G proteins. Tyrosine kinases are activated via seven-
transmembrane-domain receptors, tyrosine kinase linked-receptors and integrin engagement. 
14 
Signaling via PI3-kinase enzyme is of recent interest because of strong evidence of a very fast 
internal compass comprised of polarized phospholipids as discussed in detail below (Wong, Heit 
et al. 2010, Knall, Worthen et al. 1997). Neutrophils express PI3-kinase α, β, γ and δ isoforms. 
PI3-kinase γ is activated by heterotrimeric G-proteins whereas others are regulated by tyrosine 
kinases. Neutrophils produce highest amounts of these lipids (Stephens, Ellson et al. 2002). PI3K 
is also involved in MAPK activation (Niggli 2003). PI3Kγ, in neutrophils and not endothelium, 
is important for neutrophil emigration from circulation in response to brief stimulation and 
PI3Kδ is responsible for emigration after longer chemokine stimulation (Liu, Puri et al. 2007, 
Puri, Doggett et al. 2005, Puri, Doggett et al. 2004). Having said this, PI3Kγ is responsible for 
neutrophil chemokinesis i.e. cell motility in response to fMLP, can regulate integrins and some 
aspects of polarization but is not unique to neutrophil’s “chemotactic compass” (Andrew, Insall 
2007, Ferguson, Milne et al. 2007). LPS primed neutrophils, when exposed to fMLP, are 
completely insensitive to PI3K inibitors (Ferguson, Milne et al. 2007). These studies show an 
important context-dependent role of PI3Kγ in neutrophil motility. Shallow chemoattractant 
gradients induce random pseudopods that are split from a leading edge and finally a dominant 
pseudopod is sustained. PI3K inhibitors lead to lower frequency of pseudopod generation but do 
not affect directionality (Insall 2010, Andrew, Insall 2007). Therefore, where early PIP3 
redistribution localizes DOCK2 at the pseudopod for neutrophil chemotaxis early-on, a later 
activation of phosphatidic acid (PA) localizes DOCK2 to the pseudopod slowly to maintain 
neutrophil chemotactic response that is independent of PIP3 (Nishioka, Frohman et al. 2010, 
Nishikimi, Fukuhara et al. 2009, Kunisaki, Nishikimi et al. 2006). It seems neutrophils have 
adapted various inter-related signaling pathways for neutrophil pseudopod persistence and 
directionality. And many questions still remain to clarify the basic function of each pathway. 
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Neutrophils encounter and ‘prioritize’ many chemoattractant gradients to pursue bacteria. For 
example, neutrophils adhere to the endothelium of blood vessels in response to chemokines 
including CXCL8 (also known as IL-8). However, while still in the presence of this initial 
stimulus, they must eventually be able to respond to bacterial chemoattractants such as fMLP. 
IL-8 stimulates PI3K-phosphatase and tensin homolog (PTEN) pathway whereas fMLP 
stimulates p38 MAPK pathway with latter dominating over the PI3K pathway (Heit, Tavener et 
al. 2002, Foxman, Campbell et al. 1997). In response to IL-8, [PtIns(3,4,5)P3] is localized at the 
leading edge of migrating neutrophil and PTEN (which converts [PtIns(3,4,5)P3] to 
[PtIns(4,5)P2]) accumulates along sides and uropod of the cell (Li, Dong et al. 2005). fMLP also 
causes PTEN localization along sides and at the uropod but does not depend on [PtIns(3,4,5)P3] 
(Heit, Robbins et al. 2008). In opposing gradients, PTEN distributes all around the cell 
circumference thus inhibiting [PtIns(3,4,5)P3] and consequently allowing preferential migration 
towards bacterial products in a p38-dependent manner. Such prioritization is absent in PTEN-/- 
neutrophils resulting in compromised bacterial clearance in vivo (Heit, Robbins et al. 2008). 
Lipopolysaccharide, commonly called as LPS, is a cell wall component of Gram negative 
bacteria that blocks neutrophil migration towards chemokines such as IL-8 via Toll-like receptor 
4 (TLR4) activation leading to induction of p38-dependent inhibition of [PtIns(3,4,5)P3]. LPS 
also blocks chemotaxis in response to fMLP by an unknown mechanism (Heit, Tavener et al. 
2002). LPS itself does not have chemoattractant properties so neutrophils stop and do not 
migrate towards LPS. Although systemic administration of LPS in mice causes neutrophil 
adhesion in the microcirculation, there is no transmigration into extravascular space despite 
administration of chemoattractant (Khan, Heit et al. 2005, Yipp, Andonegui et al. 2002). 
Neutrophils are rapidly diverted towards lung and liver avoiding peripheral sites, a well observed 
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fact, under systemic LPS challenge as in sepsis (Yipp, Andonegui et al. 2002, Andonegui, 
Bonder et al. 2003). There could be four possible explanations. First, LPS activates platelet 
TLR4 that can induce neutrophil activation and neutrophil extracellular trap (NET) formation 
under flow conditions in-vivo (Clark, Ma et al. 2007). There are many reports showing presence 
of platelets, similar to neutrophils, in lungs and liver of sepsis patients and mice models of sepsis 
(Andonegui, Kerfoot et al. 2005, Stohlawetz, Folman et al. 1999, Andonegui, Trevani et al. 
1997). Mortality in sepsis patients shows direct correlation with degree of thrombocytopenia 
(Mavrommatis, Theodoridis et al. 2000). It is interesting that activated protein C, an effective 
therapeutic in severe sepsis, has both anti-thrombotic and anti-inflammatory effects. Second, 
increased expression of α4 integrin on neutrophils will make them adhere to endothelial vascular 
cell adhesion molecule 1 (VCAM1) (Ibbotson, Doig et al. 2001). Third, C5a production formed 
via the classical complement activation of C3 as well as through thrombin-dependent pathway 
activates multiple receptors (Rittirsch, Flierl et al. 2008, Huber-Lang, Sarma et al. 2006, 
Czermak, Sarma et al. 1999) and induces neutrophil recruitment in lungs. Lastly, LPS induces 
p38 MAPK activation to set up a PTEN ‘barrier’ around the entire cell thus preventing 
neutrophil response to chemotactic stimulus. This point is observed following administration of 
tumor necrosis factor alpha (TNFα), which induces p38 MAPK (Lokuta, Huttenlocher 2005). 
This suggests that LPS or TNFα facilitate recruitment of neutrophils from vasculature by 
activating endothelial cells and macrophages and preventing neutrophil migration away from 
these sites. However, these mediators may serve to distract neutrophils from being recruited to 
appropriate tissues. The impact of PI3Kγ in acute lung inflammation is exemplified by the lack 
of adequate Pneumococcus clearance in the PI3Kγ-/- mice or PI3Kγ inhibitor pretreated mice 
(Maus, Von Grote et al. 2002). This might affect immune surveillance in remote organs. This 
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situation is further compounded by the fact that LPS from certain organisms activates 
complement resulting in the generation of chemoattractant such as C5a (Czermak, Breckwoldt et 
al. 1999). 
There are some specific examples of neutrophil recruitment distractors (Hickey, Kubes 2009). 
Bacterial products such as clostridia toxin damage the vasculature and inhibit microvascular 
blood flow, thereby limiting neutrophil recruitment and oxygen delivery to the affected site 
(Hickey, Kwan et al. 2008). Staphylococcus aureus expresses numerous such molecules such as 
complement inhibitor stabilizing C3 convertases which inhibit C3b deposition to affect 
neutrophil uptake of bacteria and neutrophil chemotaxis (Rooijakkers, Ruyken et al. 2006, 
Rooijakkers, Ruyken et al. 2005). Some methicillin-resistant S. aureus strains express α-type 
phenol soluble modulin peptides, which induce neutrophil recruitment and activation and 
subsequently promote neutrophil lysis (Kretschmer, Gleske et al. 2010, Wang, Braughton et al. 
2007). Staphylococcal superantigen-like 5 binds to P-selectin glycoprotein ligand 1 (PSGL1), the 
main ligand of P-selectin, and inhibits rolling of neutrophils on endothelial cells (Bestebroer, 
Poppelier et al. 2007). S. aureus protein CHIPS (chemotaxis inhibitory protein of S. aureus) 
binds to G-protein coupled chemoattractant receptor for C5a and formyl peptides on immune 
cells, thus inhibiting binding of natural chemotactic ligands (Prat, Haas et al. 2009, Postma, 
Poppelier et al. 2004). In addition S. aureus extracellular adherence protein (Eap) binds to 
ICAM1 and inhibits β2 integrin mediated neutrophil adhesion to endothelial cells (Chavakis, 
Hussain et al. 2002). Understanding of such molecular mechanisms of disruption of neutrophil 
recruitment in response to bacteria can help in design of better therapeutics. 
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1.2 . Angiostatin (ANG) 
1.2.1. Synthesis of Angiostatin 
ANG is the cleavage product of plasminogen and is composed of first four or three 
kringle domains (Wahl, Kenan et al. 2005, O'Reilly, Holmgren et al. 1994). K-5 of plasminogen 
also shows similar activity (Lu, Dhanabal et al. 1999). The following scheme (Figure 4) depicts 
conversion of plasminogen to plasmin, reduction of plasmin by phopshoglycerate kinase (PGK) 
followed by serine proteinase dependent release of kringle (K) 1-4½ and finally matrix 
metalloproteinase (MMP)-dependent trimming of K 1-4½ to K 1-4 or K1-3 (Lay, Jiang et al. 
2000). 
Generation of angiostatic molecules in non-neoplastic settings has been previously described in 
in vitro as well as in vivo settings by proteolysis of membrane-bound plasmin (Falcone et al., 
1998). Western blots from cutaneous wound model detect ANG forms and plasminogen as early 
as day 1 and day 3 after generation of the wounds (i.e., at the initial phase of wound healing). In 
this model, wound healing is complete after 8 to 9 days. The expression of angiostatin forms 
peaked at the last phase of wound healing (day 7 after generation of the wounds), and almost 
disappeared after wound healing was complete at day 10 (Chavakis, Athanasopoulos et al. 2005). 
PMNs have been shown to mediate the initial angiogenic switch in mouse model of multi-stage 
carcinoma (Nozawa et al., 2006), release ANG with the help of MMP-9, urokinase (BENELLI, 
MORINI et al. 2002, Scapini, Nesi et al. 2002). Platelets are well known to produce ANG 
because of presence of uPA (JURASZ, SANTOS-MARTINEZ et al. 2006). Interaction of uPA 
with its cellular receptor, urokinase-type plasminogen activator receptor (uPAR) also promotes 
cellular signaling, which can influence the course of lung inflammation or cancer. A recent 
finding indicates that PGK interacts with the uPAR mRNA coding region and regulates 
expression of uPAR at the cell surface (Shetty, Idell 2004). 
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Figure 4: General Scheme of biosynthesis of two major angiostatin forms (K1-4 and K1-3). The 
rate limiting step for angiostatin biosynthesis is the activation of Plasminogen to plasmin in 
presence of urokinase (uPA) or tissue type plasminogen activator (tPA). Phosphoglycerate kinase 
(PGK) acts as a reducing agent. Each kringle (K) is a highly folded domain. K1-4 is termed as 
angiostatin. K1-41/2 and K5 also show anti-angiogenic activities. 
Pla
sm
ino
ge
n
Pla
sm
in
Blo
od
H 2
N
CO
OH
K1
K2
K3
K4
K5
uP
A/
tPA
PG
K
K 1
-41
/2
K 1
-4/
AN
G
K 1
-3
MM
P 3
, 7
, 9
, 1
2
MM
P 2
, 1
2
Pla
sm
in,
 
ser
ine
 pr
ote
ina
se
Re
du
ced
 Pl
asm
in
Dis
ulp
hid
e b
on
d
K
Kri
ng
le
do
ma
in
12
0 m
in.
20 
This mechanism represents a potential pathway by which uPAR-dependent responses of the lung 
epithelium may be controlled in the context of lung injury and repair, neoplastic transformation, 
or in the growth and spread of lung neoplasms. These extrapolations are yet to be clarified. 
1.2.2. Angiostatin Binding Proteins 
ANG binds to several endothelial cell surface proteins (Wahl, Kenan et al. 2005, Tabruyn, 
Griffioen 2007) such as ATP synthase F1F0, heat shock protein-27 (hsp-27), annexin II, αVβ3 
integrin and angiomotin (amot).  
1.2.2.1. F1F0 ATP Synthase. Binding to F1F0 ATP synthase inhibits ATP synthesis and 
hydrolysis and ultimately leads to a caspase-mediated apoptosis, and direct cell toxicity at low 
intracellular pH (Chi, Pizzo 2006, Kenan, Wahl 2005, Veitonmäki, Cao et al. 2004, Moser, Kenan et al. 2001), 
conditions that are fertile for shutting down the oxidative phosphorylation machinery in 
inflammation and tumorigenesis (Wahl, Kenan et al. 2005). Recently, a monoclonal antibody, 
MAb3D5AB1, directed against catalytic -subunit of F1F0 ATP synthase displayed similar, but 
potent, in vitro and in vivo anti-angiogenic effects compared to angiostatin (Chi, Wahl et al. 
2007). Besides, the extracellular nucleotides are emerging as potential inflammatory mediators 
as depicted by their in vitro as well as in vivo (Kukulski, Ben Yebdri et al. 2007) chemotactic or 
transmigratory roles and in vivo lung inflammation mediation through dendritic cells (Idzko, 
Hammad et al. 2007) possibly through variable purinergic receptor activation viz A3, P2Y2, 
P2Y6 (Chen, Wu et al. 2006). Human lung and blood cells have almost ubiquitously distributed 
purinergic receptors (Bours, Swennen et al. 2006). Also, the human astrocytoma P2Y2 receptor 
RGD sequences interact with αv integrins on these cells to mediate G12 chemotactic signaling 
(Liao, Seye et al. 2007). The functional consequence of angiostatin’s binding and inhibition of 
ATP synthase might as well translate into an anti-inflammatory profile. 
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1.2.2.2. Heat Shock Proteins. Binding of ANG with heat shock proteins (hsp) 27 and 70 
is also concentration and kringle dependent (Dudani, Mehic et al. 2007). Hsps are implicated in 
regulation of stress as their expression increases under heat shock, oxidant exposure and other 
environmental insults. Hsp 27 has been implicated in cell actin organization, cell growth and 
migration (Kostenko, Moens 2009). 
1.2.2.3. Annexin II, a calcium binding protein that regulates the conversion of 
plasminogen to plasmin, is also a target of ANG (Syed, Martin et al. 2007, Sharma, Rothman et 
al. 2006). Annexin II is also a substrate for src tyrosine kinase and protein kinase C that mediate 
its downstream signaling. Both ANG and plasminogen compete for annexin II binding but ANG 
has a lower dissociation constant than plasminogen, therefore acting as a physiological 
antagonist of plasminogen in mediating endothelial apoptosis and inhibition of proliferation 
(Sharma, Sharma 2007, Tuszynski, Sharma et al. 2002).  
1.2.2.4. αVβ3 Integrin. ANG also binds to αVβ3 integrin (Tarui, Miles et al. 2001) as 
evidenced by lack of stress fiber formation in Chinese hamster ovary (CHO) cells expressing β3 
integrin subunit and adhered to vitronectin. ANG with multiple kringles/integrin binding sites 
could effectively saturate αvβ3 on the cell surface without inducing signals and block the 
accumulation of plasmin on the cell surface (Tarui, Majumdar et al. 2002). ANG also induces 
apoptosis by anoikis, which is detachment of cells from the matrix leading to apopotosis. It is 
interesting that many endothelial and epithelial cells have integrin αVβ3 on their apical and basal 
surface (Singh, Fu et al. 2000). ANG could act through this integrin for aniokis.  
1.2.2.5. Angiomotin/Amot belongs to a new protein family with only two additional 
members characterized by conserved coiled-coil domains and C-terminal PDZ binding motifs 
(Bratt, Birot et al. 2005, Moreau, Lord et al. 2005, Bratt, Wilson et al. 2002), namely 
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JEAP/Amot-like 1 and MASCOT/Amot-like 2. The Amot family forms protein-protein 
complexes with MUPP1 and Patj, with Patj having higher affinity for the Amot family 
(Sugihara-Mizuno, Adachi et al. 2007). Amot was identified via its interaction with angiostatin 
in yeast two-hybrid system where it induced focal adhesion kinase (FAK) activity and amot was 
shown to localize to lamellipodia of migrating endothelial cells (Troyanovsky, Levchenko et al. 
2001a). Cell motility and cell-cell junctions are both closely regulated by the actin cytoskeleton 
and the Rho family of GTPases. It is possible that angiomotin regulates both permeability and 
motility by influencing the actin cytoskeleton (Gagne, Moreau et al. 2009). There is evidence 
that relates angiostatin and angiomotin to Rho signaling (Gupta, Nodzenski et al. 2001). 
Therefore, it would be tempting to further investigate if control of the actin cytoskeleton is at the 
heart of both properties of angiomotin (Bratt, Birot et al. 2005). Rich1 binds the scaffolding 
protein angiomotin (Amot) and is thereby targeted to a protein complex at tight junctions (TJs) 
containing the PDZ-domain proteins Pals1, Patj, and Par-3. Furthermore, the coiled-coil domain 
of Amot, with which it binds Rich1, is necessary for localization to apical membranes and is 
required for Amot to relocalize Pals1 and Par-3 to internal puncta. Rich1 and Amot, probably, 
maintain TJ integrity by the coordinate regulation of Cdc42 and by linking specific components 
of the TJ to intracellular protein trafficking as shown in MDCK epithelial cells (Wells et al., 
2006). Cdc42 is a member of the Rho GTPase family, whose members interact with effectors 
when bound to GTP and terminate signaling upon GTP hydrolysis (Hall, Nobes 2000, Nobes, 
Hall 1994). 
1.2.3. Anti-proliferative and Apoptotic Effects of Angiostatin 
Angiostatin inhibits
 
autophosphorylation of the hypoxia-induced growth factor (HGF) 
receptor (c-met), as well as downstream
 
events including the phosphorylation of Akt and 
ERK1/2 in endothelial and smooth muscle cells. The inhibition
 
appeared to be competitive, since 
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high concentrations of HGF could
 
overcome the inhibition by angiostatin (Wajih, Sane 2003). 
Akt is a serine/threonine kinase that is rapidly
 
activated as a downstream effector of 
phosphatidylinositol 3 (PI3)
 
kinase in response to a variety of cytokines and growth factors,
 
including HGF (Nakagami, Morishita et al. 2001). Akt plays multiple roles in cellular 
homeostasis
 
including the regulation of glucose metabolism (Kohn, Summers et al. 1996), the 
activation
 
of eNOS (Dimmeler, Fleming et al. 1999), and the suppression of apoptosis (Coffer, 
Jin et al. 1998). The antiapoptotic
 
effect of Akt may occur through the phosphorylation of the 
apoptosis-inducing
 
proteins BAD (Datta, Dudek et al. 1997, Del Peso, González-García et al. 
1997), caspase-9 (Cardone, Roy et al. 1998), and FKHRL1 (Brunet, Bonni et al. 1999). The 
activation
 
of Akt is also essential for the induction of a survival pathway
 
involving ligation of 
αvβ3 (or αvβ5) and resulting in the up-regulation
 
of bcl-2 expression (Matter, Ruoslahti 2001). 
The activation of the PI3K-Akt axis by
 
both integrins and growth factor receptors emphasizes the 
importance
 
of this signal pathway for cell survival. Finally, Akt promotes
 
cell-cycle progression 
into the S-phase by repressing the expression
 
of p27
kip1
, an inhibitor of the cyclin E/cdk2 
complex (Mirza, Kohn et al. 2000). 
ANG inhibits the proliferation of EC by down-regulating the protein level of cyclin-
dependent kinase (cdk) 5, a cdk absent in quiescent endothelial cells but induced after treatment 
with bFGF (Sharma, Tuszynski et al. 2004). cdk5 mediated phosphorylation results in inhibition 
of MAPkinase kinase 1(MEK1) catalytic activity and hence the phosphorylation of ERK1/2 
(Sharma, Veeranna et al. 2002). The role of MAP kinase in cellular proliferation, survival and 
differentiation is well established (Pearson, Robinson et al. 2001). ANG also acts by 
upregulating the mRNA level of FasL and reducing the level of c-FLIP, which activates the 
extrinsic apoptotic pathway (death receptor pathway). Treatment of HUVEC with ANG results 
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in induction of the intrinsic pathway (mitochondrial) by inducing p53, Bax and tBid that lead to 
the release of cytochrome-c from the mitochondria and the activation of caspase-9 (Chen, Wu et 
al. 2006). In fact, a recent study also deduces inhibition of mitochondrial proteins such as malate 
dehydrogenase and ATP synthase as the target site for ANG’s antiangiogenic and pro-apoptotic 
effects in tumor and tumor-endothelial cells (Lee, Muschal et al. 2009b). Nevertheless, ANG 
activates RhoA upon binding to EC followed by transient increase in ceramide level, which 
reorganises the actin stress fiber and finally causes cell detachment (Gupta, Nodzenski et al. 
2001). ANG-induced apoptosis is restricted to proliferating EC, which also express integrin αvβ3 
(Hari, Beckett et al. 2000). Interestingly, ANG induces the expression of adhesion molecules 
(ICAM-1, E-selectin) (Luo, Lin et al. 1998). Several recent findings suggest activation of nuclear 
factor- κB (NF-κB) to be a common mechanism of angiostatic agents to induce EC apoptosis and 
to improve immune response (Dirkx, oude Egbrink et al. 2006). Airway epithelium controls lung 
inflammation and injury through the NF-κB pathway (Cheng, Han et al. 2007). This may be 
another possible pathway for ANG to show an anti-inflammatory action in lung. ANG has 
recently been reported to upregulate the expression of antiangiogenic IL-12 (Albini, Brigati et al. 
2009). Most of the mechanistic data in the field of ANG has been derived from secondary tumor 
inhibition studies. Ample evidence indicates the protective and therapeutic role of ANG in 
treatment of various cancers like breast, prostate, small-cell lung advanced colorectal and renal 
cancer (de Castro Junior, Puglisi et al. 2006). In an explicitly studied angiogenesis model, 
differentiating eight stages of angiogenic cascade in vitro, angiostatin invariably caused inverse 
angiogenesis irrespective of the stage at which angiostatin was added (Bahramsoltani, Plendl 
2007). Overall, these data suggest a broad range of receptors for the ANG and many modes of 
action although specifics of actions are far from fully understood. 
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1.2.4. Inflammation and Angiostatin 
ANG levels are reportedly increased in acute respiratory distress syndrome and septic 
patients (ARDS) (Hamacher, Lucas et al. 2002, Lucas, Lijnen et al. 2002, Singh, Janardhan et al. 
2005). Interestingly, there are no data on the expression of ANG in endotoxin-induced acute lung 
injury or animal models of lung inflammation. Similarly, increasing amounts of ANG and related 
peptides coupled with degradation of plasminogen and lower levels of plasmin have been 
reported in wound fluid from chronic venous leg ulcers (Smith, Hoffman 2005, Hoffman, 
Starkey et al. 1998). ANG, through interaction with Mac-1 (αMβ2) integrin as well as reduced 
activation of NF-κB and related tissue factor expression, suppresses inflammation by inhibiting 
peripheral blood leukocyte recruitment and angiogenesis in a mouse model of acute peritonitis 
(Chavakis, Athanasopoulos et al. 2005). ANG inhibits HIV-Tat-induced inflammatory 
angiogenesis (Benelli, Morini et al. 2003), causes defective colonic healing (te Velde, Kusters et 
al. 2003) and has been also shown to inhibit macrophage migration by disrupting their actin 
cytoskeleton in mouse atheromas (Perri, Annabi et al. 2007, Moulton, Vakili et al. 2003). ANG 
reduces monocyte chemoattractant protein-1 levels, T-cell and macrophage infiltration in chronic 
kidney injury (Mu, Long et al. 2009). 
1.3. Synchrotron Imaging 
Synchrotron produces the light by using powerful electro-magnets and radio frequency 
waves to accelerate electrons to nearly the speed of light. Energy is added to the electrons as they 
accelerate so that, when the magnets alter their course, they naturally emit a very brilliant, highly 
focused light (http://www.lightsource.ca/education/pdf/materials/SSSRCBooklet_Final_B.pdf). 
The Canadian Light Source (CLS) has four major components (Figure 5): 
i) Electron gun and linear accelerator. An electron gun that produces pulses of electrons 
via high voltage electricity through heated cathode. The electron gun supplies electrons to 
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the Linear Accelerator (LINAC). The electrons are accelerated by microwaves to 250 
MeV. 
ii) Booster ring. Microwaves further accelerate the electrons by increasing the energy from 
250 MeV to 2900 MeV. 
iii) Storage ring. Insertion devices like wigglers and undulators bend the beam many times 
over very short distances. 
iv) Beamlines and End-stations. High-speed high-energy electrons accelerated or bent by 
powerful magnets produce an extremely brilliant, full spectrum beam of photons known 
as synchrotron light. There are fourteen beamlines and eight other under construction at 
CLS. Monochromators split the synchrotron light into portions of electromagnetic 
spectrum which is then focussed with specially curved mirror systems. The selected 
wavelength of synchrotron light is directed onto the sample and detected with specialized 
detectors depending upon the application. 
Synchrotron sources of light pack more photons into a smaller beam of light as shown in 
Figure 5 left panel. 
Dynamic imaging of small lung airways remains a challenge despite wide strides in imaging 
relatively static tissue beds. X-rays are still the only available diagnosis for lung pathologies that 
utilise absorption to highlight the hard tissue from soft tissue. However, this does not resolve soft 
tissues such as lungs. Positron emission tomography and magnetic resonance imaging offer 3D 
imaging of soft tissue excluding small airways of lungs. Synchrotron radiation computed 
tomography (SRCT) offers the highest level of spatio-temporal resolution for pre-clinical X-ray 
CT such as dynamic lung imaging through dual-energy SRCT and K-edge subtraction (KES) 
imaging using iodine or xenon as contrast agent allows simultaneous functional and 
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morphological studies, perfusion measurements of any organ like brain and all this can be 
achieved with comparably low radiation doses (Adam, Bayat et al. 2009). 
1.3.1. Phase Contrast Imaging. Phase contrast x-ray imaging utilizes refractive index 
variations (phase information) in addition to conventional absorption information to produce x-
ray images of tissues with greatly enhanced contrast, compared with conventional x-ray 
absorption techniques. It is able to achieve this because the parameter describing the phase shift 
of the x-rays is generally more than three orders of magnitude greater than the absorption term 
over the diagnostic x-ray energy range (20 keV–90 keV) (Lewis, Yagi et al. 2005). As a result, 
the phase shift of an x-ray beam propagating through tissue can be much larger than the 
absorption change and if phase effects are rendered visible they can enhance image contrast. An 
important consequence of this is that phase contrast images can be recorded with significantly 
lower dose than conventional images (Lewis 2004) which is particularly important for both 
longitudinal studies and dynamic studies especially those requiring repeated imaging. 
Several techniques have been employed to realize phase contrast x-ray imaging, but in the 
experiments reported here, I utilized the simplest method which is known as propagation-based 
phase contrast imaging (Wilkins, Gureyev et al. 1996, Snigirev, Snigireva et al. 1995).This 
modality is a form of in-line holography, which has alternatively been named ‘refraction 
enhanced imaging (Suzuki, Yagi et al. 2002, Yagi, Suzuki et al. 1999). The method is 
straightforward and differs from conventional x-radiography only in that the object and detector 
are separated by a sufficient distance to allow the refracted rays to diverge from the undeviated 
ones. The amount of phase contrast depends upon the object–detector separation. If this is small, 
as in the conventional x-ray imaging, the deviated and the undeviated x-rays are not resolved by 
the detector and no phase contrast is observed. The technique works with both coherent 
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synchrotron radiation (Snigirev, Snigireva et al. 1995) and conventional micro-focus x-ray 
sources (Wilkins, Gureyev et al. 1996). However, the unique properties of synchrotron radiation, 
in particular its brightness, make it ideal for these experiments. The small source size and 
inherent collimation yields excellent phase contrast, whilst the large beam intensity allows 
monochromatic radiation and short exposure times. With this configuration and a high-speed 
detector, it is possible to acquire dynamic images with relative ease. 
1.3.2. Diffraction Enhanced Imaging (DEI) derives contrast from an object’s X-ray 
absorption, refraction gradient and ultra-small angle x-ray scatter properties (extinction) 
(USAXS) (Figure 6a) (Hasnah, Chapman 2008, Chapman, Pisano et al. 1998, Chapman, Nesch 
et al. 2006). Images are acquired with analyser crystal set on each side of the rocking curve. The 
analyser crystal serves to diffract the beam from the object that is dependent upon the refractive 
index differences within the object in addition to X-ray absorption and scattering (Chapman, 
Thomlinson et al. 1997). 
Lungs are an excellent choice for DEI due to its soft tissue, air-filled alveoli that scatter 
light.  This scattering is a metric of the projected number of air filled alveoli (Figure 6b).  Thus, a 
larger amount of scatter implies a larger number of air filled alveoli.  This scatter is reflected in 
the width of the scattering distribution measured with DEI. The DEI images can be obtained over 
both sides of the rocking curve that are indicative of the scatter produced by lungs. Synchrotron 
imaging may be highly useful in evaluating dynamics of lung inflammation and to investigate the 
therapeutic impact of new drugs on lung inflammation. 
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Figure 5: Left panel shows synchrotron light flux. Right figure shows the four components of 
CLS (Reproduced from 
http://www.lightsource.ca/education/pdf/materials/SSSRCBooklet_Final_B.pdf). 
Object
Analyzer Synchrotron DEI Setup
Area Detector
Dean Chapman
 
Figure 6a: Schematic arrangement of the diffraction-enhanced imaging or analyzer-based 
imaging system. The beam, monochromatized by a perfect crystal pair (monochromator), is 
passed through the object and then is analyzed by a matching crystal. (Reproduced from 
Chapman, 2011). 
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Figure 6b: A schematic illustrating scatter properties of lungs. Scattering is a metric of the 
projected number of air filled alveoli. For details refer text. 
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1.4. Summary and Conclusions 
So far we have understood that neutrophils are the prime cells recruited and activated in 
response to an acute inflammatory stimulus. Acute lung injury involves a wide subset of diseases 
that result in high mortality principally due to lung and liver damage. The mechanisms of 
directed neutrophil recruitment are many with still a lot of unifying mediators left to be 
understood especially in lung. As ANG is an antiangiogenic molecule with potential anti-
migratory activities as described in-vitro and in peripheral acute inflammation model in mice 
(BENELLI, MORINI et al. 2002), my study was designed to study the specific role of ANG in 
acute lung injury and on neutrophil biology. 
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CHAPTER 2 
HYPOTHESES AND OBJECTIVES 
2.1. Hypotheses: 
1. ANG inhibits neutrophil chemotaxis and activation by binding to αvβ3 integrin. 
2. ANG inhibits leukocyte migration under flow conditions. 
3. ANG inhibits acute lung injury in mice. 
 2.2. Objectives: 
1. To characterize the role of ANG on neutrophil biology and study ANG binding 
proteins 
a. To evaluate the effect of ANG on isolated mice and human neutrophil 
chemotaxis and activation in response to fMLP and LPS respectively. 
b. To image putative ANG binding proteins for co-localization like αvβ3 integrin, 
F1F0 ATP synthase, hsp-27 and angiomotin in activated neutrophils using 
confocal imaging. 
2. To study the role of ANG on leukocyte recruitment in cremaster muscle. 
3. To characterize the ANG function in LPS induced mice model of acute lung injury 
and to see real-time lung dynamics and evaluate the role of ANG in mice imaged 
through DEI and phase-contrast imaging. 
2.3. Rationale for the Conducted Experiments  
i.) Chemotaxis of activated neutrophils is an essential early step in host defense towards the 
site of injury. Activated neutrophils live longer and are responsible for collateral tissue 
damage and multiple complications in the injured organs (Witko-Sarsat, Rieu et al. 2000, 
Witko-Sarsat 2010) through release of inflammatory products like proteinases, cationic 
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polypeptides, cytokines and reactive oxygen species (ROS) (Witko-Sarsat, Rieu et al. 
2000, Dallegri, Ottonello 1997, Haslett 1999, Haslett, Savill et al. 1989, Witko-Sarsat 
2010). As a first step towards understanding the effect of ANG on neutrophil chemotaxis, 
I chose to observe the uptake and molecular actions of ANG on isolated mice and human 
neutrophils towards bacterial chemotactic peptide, fMLP. The uptake of ANG by normal 
and activated neutrophils was explored through evaluation of various putative ANG 
receptors such as αvβ3 integrin, F1F0 ATP synthase, hsp-27, and angiomotin. Because 
there are very little data on the actions of ANG on the chemotaxis of neutrophils, I 
examined the actions on cell signaling, cytoskeletal reorganization, cell activation and 
apoptosis through the use of various methods.  
ii.) There is a need to evaluate new molecules to modulate the behavior of neutrophils in vivo 
to fine-tune inflammatory responses. In second set of experiments, I examined actions of 
ANG on leukocyte migration under flow conditions through measurement of various 
steps such as tethering, rolling, crawling, and transmigration that are involved in the 
migration of neutrophils (Ley, Laudanna et al. 2007), (Liu, Kubes 2003). I imaged the 
neutrophil recruitment in a cremaster model of TNFα-induced neutrophil migration. This 
technique has been standardized for unbiased quantification of leukocyte migration in-
vivo (Cara, Kubes 2003). 
iii.) Acute lung injury is characterized by the migration of activated neutrophils into lung 
vasculature and alveoli (Matute-Bello, Martin 2008, Perl, Lomas-Neira et al. 2008). 
These activated neutrophils live longer and cause significant tissue damage through 
inflammatory products like proteinases, cationic polypeptides, cytokines and reactive 
oxygen species (ROS) (Witko-Sarsat, Rieu et al. 2000, Dallegri, Ottonello 1997, Haslett 
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1999, Haslett, Savill et al. 1989, Witko-Sarsat 2010). The paradox of neutrophil biology 
is highlighted by the fact that although activated neutrophils are essential for clearing of 
bacteria, the tissue damage caused by them is believed to be the cause of organ failure, 
morbidity and mortality. ANG levels are reportedly increased in acute respiratory distress 
syndrome patients (Hamacher, Lucas et al. 2002, Lucas, Lijnen et al. 2002), which along 
with high levels of TNF- have been implicated in in vitro endothelial cell cytotoxicity 
that is indicative of its potential role in ARDS-related EC injury (Hamacher, Lucas et al. 
2002). Currently, there are no data on the effects of ANG in acute lung injury. Therefore, 
role of ANG was investigated in mouse model of lipopolysaccharide-induced acute lung 
injury. Intranasal bacterial endotoxin was utilized, which is a well established and non-
invasive model of lung inflammation (Szarka, Wang et al. 1997). 
iv.) Lastly, I imaged real-time lung dynamics using state-of-the art synchrotron radiation 
facility at Canadian Light Source (CLS), housed at University of Saskatchewan. This 
study was undertaken with two objectives in mind, one to establish an imaging system for 
live mice lung imaging and secondly to evaluate the role of ANG in this imaging system. 
Lungs are an excellent choice for DEI due to its soft tissue, air-filled alveoli that scatter 
light.  This scattering is a metric of the projected number of air filled alveoli. This allows 
time-dependent imaging in a mouse avoiding need of higher number of animals required 
for understanding ALI dynamics in a conventional model. Diffraction enhanced imaging 
(DEI) and phase contrast imaging modalities were utilized for this study. The basic mice 
model of ALI was same as in the above stated in-vivo ALI study. At the end of imaging, 
lungs were collected for histology to re-affirm my findings. 
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CHAPTER 3 
ANGIOSTATIN INHIBITS NEUTROPHIL MIGRATION AND ACTIVATION 
3.1. Abstract 
Angiostatin is an anti-angiogenic molecule. I studied the role of angiostatin in neutrophil 
recruitment iv-vivo and iv-vitro. Angiostatin inhibited MAPK signalling, cytoskeletal 
reorganization and formation of leading edge in neutrophils activated with fMLP and LPS. 
Angiostatin blocked formation of reactive oxygen species, activated caspase-3 and induced 
apoptosis in pre- as well as post-LPS-activated neutrophils.  Finally, the data show reduced 
adhesion and emigration of neutrophils in post-capillary venules in TNFα-treated cremaster 
muscle. 
3.2. Introduction 
Many acute inflammatory conditions such as peritonitis, pneumonia, sepsis, or sterile 
injury are marked by chemotaxis of activated neutrophils, an essential early step in host defense, 
towards the site of injury. Activated neutrophils live longer and are responsible for collateral 
tissue damage and multiple complications in the injured organs (Witko-Sarsat, Rieu et al. 2000, 
Witko-Sarsat 2010). Therefore, one of the critical needs is to identify molecules to regulate 
neutrophil migration and to silence activated neutrophils to prevent exuberant tissue damage. 
Directed neutrophil migration is explained through signal-centred and pseudopod-centred 
theories. Both these theories approach directionality through specific signalling molecules or 
development of one of the random pseudopods up the chemoattractant gradient (Insall 2010, 
Insall, Machesky 2009). At a molecular level, filamentous (F) actin aggregation supports 
extension of a major pseudopod also known as the leading edge. Chemoattractants bind to G-
protein coupled receptors that signal through βγ subunits via GTP bound small G-proteins like 
Rho, Rac, cdc42. Two functionally antagonistic enzymes, guanine nucleotide exchange factors 
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(GEFs) such as DOCK2 and GTPase activating protein (GAP) like p190 Rho GAP regulate GTP 
levels for its continuous recycling during adhesion-deadhesion in neutrophil chemotaxis. During 
these events the microtubule complex destabilizes through hsp-27 phosphorylation in favour of a 
major pseudopod (Jog, Jala et al. 2007, Hino, Hosoya 2003). Actin and microtubule filaments, 
therefore, are the primary cytoskeketal filaments involved in neutrophil chemotaxis. 
Angiostatin (ANG) binds to several cell surface proteins 7, 8 such as ATP synthase F1F0, 
heat shock proteins (hsp)-27 (Dudani, Mehic et al. 2007), annexin II (Syed, Martin et al. 
2007),(Sharma, Rothman et al. 2006), αVβ3 integrin (Tarui, Miles et al. 2001) and angiomotin 
(AMOT) (Troyanovsky, Levchenko et al. 2001b) induces anoikis and apoptosis, and inhibits 
endothelial and epithelial cell migration. Integrin αvβ3 is of particular interest in this context as it 
is expressed on the apical and basal surfaces of endothelial and epithelial cells (Singh, Fu et al. 
2000). AMOT can bind to Rho GAP through coiled-coil or PDZ domains and induce a polarised 
scaffold in haptokinetic cells. ANG inhibits peripheral blood leukocyte recruitment and 
angiogenesis in a mouse model of acute peritonitis (Chavakis, Athanasopoulos et al. 2005). The 
detailed and precise molecular mechanisms of effects of angiostatin on neutrophil biology are 
not known. I report the novel data that angiostatin silences activated neutrophils through 
inhibition of MAPK cell signals, cytoskeletal reorganization, reactive oxygen species formation 
and induction of activated caspase-3. Angiostatin also inhibits neutrophil migration in an iv-vivo 
model of inflammation. 
3.3. Materials and Methods 
Lipopolysaccharide, LPS 0127:B8 (L4516) , Cytochalasin D (C2618), FluoroTag FITC 
Conjugation Kit (FITC1) and Methyl-β-cyclodextrin (C4555) were obtained from Sigma 
Chemicals, (St. Louis, MO, USA); angiostatin K1-4 was from Haematologic Technologies Inc., 
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(Essex Junction, VT, USA); recombinant murine TNFα, R&D Systems, (Minneapolis, MN, 
USA), Vectashield Hard Set Mounting Media with DAPI from Vector Laboratories, 
(Burlingame, CA, USA). Rhodamine phalloidin, reduced mitotracker orange (M7511), IMAGE-
iT LIVE Green ROS Detection Kit (I36007), Alexa fluor 633 conjugated secondary goat anti-
rabbit (A2107) and anti-mouse (A21052) antibodies were purchased from Invitrogen, (Carlsbad, 
CA, USA). Alexa 555 anti-α-tubulin (05-829X-555), β3 blocking antibody clone LM609 
(MAB1976H) were from Millipore, (Billerica, MA, USA). Mouse anti ATP synthase β subunit 
primary antibody (ab5432) was purchased from Abcam, (Cambridge, MA, USA). Donkey anti-
goat allophyocyanin conjugated secondary antibody (sc-3860), goat anti-mouse β3 subunit (sc-
6627), goat anti-angiomotin s-20 (sc-82494) and rabbit anti-phospho HSP-27 ser82 (sc-101700) 
were from Santa Cruz Biotechnology Inc., (Santa Cruz, CA, USA). Rabbit anti-phospho p38 
MAPK (4511) and anti-phospho p44/42 MAPK (4370) antibody were from New England 
Biolabs Inc., (Ipswich, MA, USA). Rabbit anti-cleaved caspase-3 antibody (IMG 5700) was 
from Imigenex, (San Diego, CA, USA). Mouse anti-flotillin-1 (610820) and anti-flotillin-2 
(610384) was from BD biosciences, (San Jose, CA, USA). All other chemicals (if not specified) 
were purchased from Sigma Chemicals. 
3.3.1. Animal Care Ethics and Human Research Ethics 
All the animals and protocols (protocol # 20070065) were approved by Research Ethics 
Board of University of Saskatchewan, Saskatoon, Canada. Male C57BL/6 mice were procured 
from Animal Resource Centre and housed at Animal Care Unit at University of Saskatchewan. 
The study of neutrophils from healthy human volunteers was approved (#10-103), and informed 
consent was obtained from all subjects. 
3.3.2. FITC Conjugation of ANG 
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Fluorotag kit from Sigma was utilized for ANG conjugation to FITC in order to visualize 
ANG in neutrophils. An F/P ratio (i.e. FITC to protein ratio) of 4:1 was achieved after 
conjugation with a final FITC-ANG concentration of 26.7 μg/ml according to small scale 
production protocol. Extinction coefficient of unconjugated ANG as per manufacturer data sheet 
is 1.74 at 1 mg/ml. 
3.3.3. Isolation of Mice and Human Neutrophils  
Briefly, peripheral blood was withdrawn by cardiac puncture after ketamine/xylazine 
anaesthesia from mice and from intercubital vein of healthy humans. Blood was carefully 
overlayed onto a discontinuous gradient of Histopaque-1119, 1083 and 1077 according to an 
established protocol (Nuzzi, Lokuta et al. 2007). After centrifugation at 700g, the neutrophil rich 
layer at the interface of Histopaque 1119 and 1083 was aspirated. Mice red blood cells (RBCs) 
were lysed with ACK buffer for 3 minutes whereas human RBCs were subjected to hypotonic 
lysis and the neutrophil pellet was used for further experiments. The procedure yielded > 95% 
viable neutrophils upon trypan blue exclusion and staining cytospins for differential leukocyte 
count. 
3.3.4. Confocal Microscopy  
Confocal images were taken using Leica TCS SP5 (Germany). Images were acquired 
using a 63X/1.20 oil objective (Leica Plan Apochromat). Neutrophils were equilibrated for one 
hour before subjecting them to pre-treatment with PBS, 12.5 μg/ml ANG/FITC-ANG or 100 μM 
cytochalasin D for 30 minutes after a cocktail of the respective tagging dyes like rhodamine 
phalloidin in combination with saponin had been added. In case of immunofluorescence, 
neutrophils were adhered to 12mm circle coverslips coated with fetal bovine serum (FBS) or 
vitronectin for 5 minutes. Thereafter, neutrophils (0.8 X 10
6
/ml) were stimulated with 1 μM 
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fMLP for 1 minute or 1 µg/ml LPS for 30 minutes, 4 hours or 8 hours to initiate formation of 
leading edges or stimulation of MAPKinases or caspase-3 cleavage, respectively. SB230963 was 
added at 500 nMol/l, U0126 at 1 μMol/l and MCD was added at 1mMol/l for 30 minutes 
according to the experiment. Neutrophils were immediately fixed with 4% paraformaldehyde for 
15 minutes and labelled for standard immunofluorescence labeling (Nuzzi, Lokuta et al. 2007). 
The slides were mounted with vector hard setting mounting media that contained DAPI for 
identification of nuclear morphology. 
For the ROS assay, neutrophils were pre- or post-treated with ANG where necessary 
followed by 1 µg/ml LPS for 30 minutes and incubated with dye for further 30 minutes before 
coverslipping and confocal imaging. 
For activated caspase-3 staining, neutrophils were either incubated with ANG for 30 
minutes followed by LPS 1µg/ml incubations for varying time periods from 2, 4, 6, 8 to 16 hours 
or 1 µg/ml LPS was incubated for 2 hours followed by 4 hour ANG treatment. 
3.3.5. Western Blots 
Isolated human neutrophils were subjected to a 30 min treatment with vehicle, ANG, SB 
230963 or U0126 before activating them with 1 µg/ml LPS for 30 minutes. The reaction was 
terminated by adding cold lysis buffer followed by extraction and centrifugation. Equal protein 
across groups was loaded and subjected to electrophoresis in 12% SDS-PAGE (180 V), 
transferred onto nitrocellulose membrane (100 V, 60 min.), blocked with 5% BSA-0.1% PBST 
and immunoblotted for phoshorylated p38 MAPK, p44/42 MAPK or phsp-27. Membranes were 
washed with 2.5% BSA-0.05% PBST and developed with chemiluminescence using GE ECL 
blot detection reagent. 
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3.3.6. Intravital Cremaster Muscle Preparation 
To evaluate the effects of ANG on leukocyte adhesion and emigration iv-vivo, I 
performed intravital microscopy of the cremaster muscle. Mice were divided into four groups: 
negative control saline treated (n=10), positive control TNFα treated (n=9), ANG treated (n=5) 
and TNFα + ANG treated (n=5). TNFα was injected intrascrotally at a concentration 0.5 μg/0.05 
ml, 3 hours prior to recording. For TNFα + ANG group, ANG was employed along with TNFα at 
a dose of 260 μg/mice intrascrotally in a 0.1ml volume. Mice were anaesthetized at a dose of 100 
mg/kg ketamine + 10 mg/kg xylazine intraperitoneally. The cremaster muscle was carefully 
exteriorised to avoid activation and tied onto a custom made cremaster board (University of 
Saskatchewan, Engineering shop). The muscle was neither stretched too far nor was it let loose 
on the stage. After 30 minute stabilization, an unbranched post-capillary venule of 25-40 μm 
diameter was recorded for 5 minutes at 3 h, 3.5 h, 4 h, 4.5 h and 5h time points after specific 
treatment. An infra-red lamp maintained the body temperature in case of any anaesthetic-induced 
hypothermia. During the entire experiment, the muscle was superfused with bicarbonate buffer 
continuously bubbled with air to maintain a pH of 7.4. A BX51 Olympus microscope with a 
Gibraltar stage was utilized for capturing brightfield images with 10X and 20X objectives 
coupled to cannon high definition digital video recording. At the end of the experiment, 
heparinised peripheral blood was withdrawn by cardiac puncture for total and differential 
leukocyte counts, and cremaster tissue was fixed in 4% paraformadehyde for H&E staining.  
For image analysis, the recorded video sequences were projected onto a monitor and 
analysed off-line for rolling flux (cells/min), rolling velocity (μm/s), adherent cells per 100 μm 
vessel segment length and emigrated cells per 100 μm vessel length that include any cells that 
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had emigrated below or above the vessel in the cremaster preparation. Rolling flux is described 
as the average number of leukocytes crossing a fixed reference line perpendicular to the axis of 
flow in one minute. Rolling velocity is calculated by measuring the time required for the first 
twenty rolling leukocytes to cross a distance of 100 μm along the vessel. Adhesion is defined as 
the number of leukocytes adhering to the vessel wall for a minimum of 30 seconds within a 
vessel segment of 100 μm in length. Emigration is defined as the number of cells that can be 
observed outside the vessel and in the interstitial space within the field of observation at 20X. 
3.4. Statistical Analysis 
Data from intravital experiments are expressed as means ± SEMs. Shapiro-wilk test was 
employed for assessing normality of data and equivalence of variance within groups was 
ascertained by Barlett’s test utilizing Stata/SE 10.0 software (Texas, US). Results were analysed 
by application of one-way ANOVA and unpaired t-test to assess differences between two groups 
followed by Bonferroni’s all group comparison utilizing Graphpad software. A minimum p level 
of 0.05 was pre-set to establish statistical difference. 
3.5. Results 
3.5.1. FITC-ANG is internalized only by activated neutrophils and colocalizes with 
β3 integrin and lipid raft markers 
Immunolocalization of ANG, to visualize its cellular interaction and uptake, is impossible 
because the available ANG antibody also reacts with plasminogen and other angiostatin forms. I 
circumvented this problem by conjugating ANG to FITC (fluorescein isothiocyanate) to directly 
demonstrate surface and cytosolic localization of ANG in the fMLP activated but not resting 
neutrophils (Figure 7a).  
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Figure 7a: Localization of FITC-ANG in mice neutrophils. (n=3). Suspended mouse neutrophils 
(0.8 X 10
6
 cells/ml) were pretreated with PBS or 12.5 µg/ml FITC-ANG for 30 min. and then 
treated with PBS or 1µM fMLP for 1 min. and then fixed with 4% paraformaldehyde for 15 min. 
before  making cytospin slides and then coverslipped using hard-set DAPI mounting media. Note 
the absence of staining for FITC-ANG in resting neutrophils. Short arrow head indicates the 
membrane staining and long arrow indicates internalization of FITC-ANG in fMLP activated 
neutrophils. 
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Figure 7b: Localization of 3 integrin subunit (in red) and FITC-ANG (in green) in PBS or 1µM 
fMLP (1 min.) stimulated mouse neutrophils (0.8 X 10
6
 cells/ml) adhered on FBS coated 
coverslips. Note attenuation of polarised distribution in ANG group. (n=3) Arrows indicate the 
polarised distribution of 3 integrin subunit. Please note that merge for the last treatment group, 
i.e. ANG+fMLP, shows merge of DAPI (blue), 3 integrin subunit (red) and FITC-ANG (green).
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β3 integrin is, a receptor of ANG, localized in a Ca2+ dependent manner to the leading edge 
during chemotaxis on vitronectin (Hendey, Lawson et al. 1996, Lawson, Maxfield 1995). I 
noticed expression pattern of β3 integrin in fMLP-stimulated mice neutrophils on vitronectin 
similar to that of ANG. Also, ANG colocalized with and abolished polarized distribution of β3 
integrins (Figure 7b).           
  I examined the role of lipid rafts in the uptake of FITC-ANG. Lipid rafts are cell 
signalling platforms and have a proven role in endocytosis (Singh, Marks et al. 2010). I 
examined redistribution of lipid raft markers, flotillin-1 and flotillin-2, in fMLP and LPS 
stimulated human neutrophils along with reduced mitotracker dye as a marker of neutrophil 
activation. The dye fluoresces upon oxidation and stains mitochondria based on the membrane 
potential. fMLP as well as LPS light up the reduced dye indicating neutrophil activation (Figure 
7c). ANG attenuates the expression of reduced mitotracker in neutrophils activated with fMLP or 
LPS. Expression of FITC-ANG superimposed on flotillin-2 and flotillin-1 in fMLP or LPS 
activated neutrophil which suggests a role for lipid rafts in endocytosis of ANG in activated 
human neutrophils (Figure 7c). To further examine the role of lipid rafts in uptake of FITC-
ANG, human neutrophils were pre-incubated with 1 mM methyl-β-cyclodextrin (MCD) that 
disrupts lipid rafts by depleting cholesterol followed by activation with fMLP. MCD completely 
inhibited the uptake of FITC-ANG and actin aggregation was restored (Figure 7d). 
3.5.2. ANG abolishes formation of leading edges in response to fMLP in 
neutrophils 
Because chemotaxis involves formation of leading edges, also known as pseudopods 
(Insall 2010), I examined the cytoskeletal dynamics in fMLP-activated mouse and human 
neutrophils with or without ANG. ANG pre-treatment prevented reorganization of actin 
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filaments and formation of polarized head (Figure 8a and Figure 8b). Mouse neutrophils treated 
with cytochalasin D also failed to develop the leading edge (Figure 8a) in response to fMLP. 
Because ANG has been reported to bind αVβ3 integrin (Tarui, Miles et al. 2001), I treated human 
neutrophils with a humanised function blocking αVβ3 antibody (clone LM609) to block the 
integrin binding with ANG. LM609 blocked actions of ANG and led to polarization evidenced 
by actin staining pattern (Figure 8b). 
3.5.3. ANG stabilises and colocalizes with microtubule network in fMLP-
stimulated neutrophils 
Microtubules are destabilized in fMLP stimulated neutrophils (Eddy, Pierini et al. 2002). 
ANG stabilized and co-localized with α-tubulin (tubulin) in fMLP stimulated human neutrophils 
(Figure 8c and Movie 1). Phosphorylated heat shock protein-27 (phsp-27) and angiomotin 
(AMOT) are known to interact with ANG (Dudani, Mehic et al. 2007, Wells, Fawcett et al. 
2006). As reported by others (Jog, Jala et al. 2007, Hino, Hosoya 2003), I observed 
colocalization of phsp-27 with tubulin in resting as well as fMLP stimulated human neutrophils, 
and that fMLP produces a strong polarization of phsp-27 and tubulin. ANG treatment reduced 
the expression of phsp-27 after fMLP stimulation and stabilized the tubulin network in contrast 
to the microtubules in fMLP stimulated human neutrophils (Figure 9a). Western blots showed 
reduced expression of phsp-27 in ANG-treated LPS-activated human neutrophil (Figure 9b). 
AMOT is recognised, from a yeast two-hybrid screen, as an ANG binding protein. While 
it is widely expressed in endothelial and epithelial cells, its transcript is expressed in neutrophils 
too (BENELLI, MORINI et al. 2002). 
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Figure 7c: Immunofluorescence of flotillin-1 and flotillin-2 (in fuschia), reduced mitotracker (in 
red) and FITC-ANG (in green) in 1µg/ml LPS (30 min.) and 1µM fMLP (1 min.) stimulated 
human neutrophils (0.8 X 10
6
 cells/ml) adhered on FBS coated coverslips. Note attenuation of 
signal for reduced mitotracker in FITC-ANG incubated cells. FITC-ANG colocalizes with lipid 
raft markers, flotillin-1 and flotillin-2. (n=3). Arrows indicate flotillin distribution upon ANG 
and fMLP or LPS treatment. Please note that merge for the last treatment group i.e. ANG+fMLP 
or LPS show merge of DAPI (blue), reduced mitotracker (red), flotillin (fuschia) and FITC-ANG 
(green). 
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Figure 7d: Localization of Alexa 555 phalloidin (in red) and FITC-ANG (in green) in 1µM 
fMLP (1 min.) stimulated human neutrophils (0.8 X 10
6
 cells/ml) pretreated with 1mM MCD (30 
min.) adhered on FBS coated coverslips. MCD treatment abolished uptake of FITC-ANG but 
does affect cortical actin aggregation and leading edge formation. Arrows indicate leading edge. 
(n=3) 
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Figure 8a: Effect of ANG on actin cytoskeleton in mice neutrophils. Suspended mouse 
neutrophils (0.8 X 10
6
 cells/ml) were pretreated with PBS or 12.5 µg/ml FITC-ANG or 100µM 
cytochalasin D for 30 min. and then treated with PBS or 1µM fMLP for 1 min. and then fixed 
with 4% paraformaldehyde for 15 min. before making cytospin slides and then coverslipped 
using hard-set DAPI mounting media. Actin is stained in red. Arrows indicate actin aggregation 
of neutrophils. Note attenuation of polarized head in 1µM fMLP incubated cells treated with 
ANG.  (n=3) 
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Figure 8b: Localization of actin (in red) and FITC-ANG (in green) in PBS or 1µM fMLP (1 
min.) stimulated human neutrophils (0.8 X 10
6
 cells/ml) adhered on FBS coated coverslips. Note 
attenuation of polarized head in fMLP incubated cells treated with 12.5µg/ml ANG. ANG could 
not abolish aggregation in αvβ3 LM609 (1:100 dilution) pretreated neutrophils. Arrows indicate 
actin aggregation. (n=3) 
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Figure 8c: Localization of -tubulin (in red) and FITC-ANG (in green) in PBS or 1µM fMLP (1 
min.) stimulated human neutrophils adhered on FBS coated coverslips. Note stabilization as well 
as colocalization of tubulin network with 12.5µg/ml FITC-ANG incubated cells. Arrows indicate 
destabilized -tubulin (n=3). Please note that merge for the last treatment group i.e. ANG+fMLP 
shows merge of DAPI (blue), -tubulin (red) and FITC-ANG (green). 
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Figure 9a: Immunofluorescence of phosphorylated hsp-27 (phsp-27) (in cyan) and -tubulin (in 
red) in fMLP (1 min.) stimulated human neutrophils (0.8 X 10
6
 cells/ml) adhered on vitronectin 
coated coverslips. Note stabilization of tubulin network with 12.5µg/ml ANG+fMLP treated 
neutrophils. (n=3) 
Figure 9b: Expression of phsp-27 in human neutrophil lysates subjected to SDS electrophoresis. 
Human neutrophils (2 X 10
6
/ml) were activated with 1µg/ml LPS for 30 min. Note attenuation of 
phsp-27 in 12.5µg/ml ANG as well as 500nM SB239063 treated neutrophils. The graph depicts 
percent inhibition of the expressed protein where LPS represents 100% of the protein. Statistical 
differences at p < 0.05 are indicated by asterisks (*). 
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Figure 9c: Immunofluorescence of angiomotin (AMOT) (in cyan) and -tubulin (in red) in 1µM 
fMLP (1 min.) stimulated human neutrophils (0.8 X 10
6
 cells/ml) adhered on vitronectin coated 
coverslips. Note stabilization of tubulin network with ANG+fMLP treated cells. (n=3) 
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Moreover, AMOT possesses various conserved domains such as the coiled-coil, PDZ binding, 
proline rich and ANG binding domain (Bratt, Wilson et al. 2002, Bratt, Wilson et al. 2003). 
AMOT co-localized with the tubulin network in resting as well as fMLP-treated human 
neutrophils (Fig. 9c). 
fMLP induces polarization of AMOT as well as the alpha-tubulin (Figure 9c). ANG 
pretreatment stabilized the tubulin and reduced expression of AMOT (Figure 9c). Collectively, 
ANG’s effects on phsp-27, alpha-tubulin and AMOT may result in inhibition of chemotaxis and 
promote maintenance of cell shape in activated neutrophils. 
3.5.4. ANG co-localizes with mitochondria in vitronectin adhered neutrophils 
Neutrophil activation involves mitochondrial reorganization in order to orchestrate 
chemotaxis, phagocytosis and ROS production (Fossati, Moulding et al. 2003). Mitochondrial 
ATP synthase, upon translocation to the plasma membrane, is proposed to bind ANG (Lee, 
Muschal et al. 2009a). Reduced mitotracker dye, which binds to mitochondria in the presence of 
reactive oxygen species, stained active mitochondria in fMLP or LPS-activated mouse and 
human neutrophils in suspension or those adhered to fetal bovine serum or vitronectin (Figure 
10a). FITC-ANG attenuated the expression of reduced mitotracker dye in suspended or adhered 
neutrophils treated with LPS or fMLP (Figure 10a). Mouse neutrophils stimulated with LPS and 
adhered to vitronectin showed partial co-localization of ANG with reduced mitotracker dye 
(Figure 10a; Movie 2). Furthermore, ANG attenuated F1F0 ATP synthase expression in LPS–
stimulated human neutrophils (Figure 10b, 10c). 
3.5.5. ANG shuts down p38MAPK signalling and reactive oxygen species formation 
(ROS) 
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I investigated the impact of ANG on MAPK because p38 MAPKinase is implicated in 
cell migration signalling (Niggli 2003, Spisani, Falzarano et al. 2005) and p44/42 MAPKinase or 
ERK1/2 is involved in activation of NADPH oxidase required for generation of reactive oxygen 
species (ROS) (Markvicheva, Gorokhovatskii et al. 2010). Mouse as well as human neutrophils 
activated with LPS show strong expression for phosphorylated p38 and p44/42 MAPKinases 
(Figures 11a, 11b, 11d) and ANG attenuates their expression (Figures 11a, 11b, 11d). Western 
blots also showed that ANG treatment attenuated the expression of phosphorylated p38 and 
p44/42 MAPK (Figures 11c and 11e). p38 and p44/42 MAPKinase inhibitors SB239063 and 
U0126, respectively, reduced the expression of respective MAPK (Figures 11c and 11e) in LPS-
stimulated human neutrophils. 
Furthermore, ANG attenuated ROS production in LPS-treated human neutrophils 
(Figures 12a and 12b) hence confirming my earlier observation where ANG attenuates reduced 
mitotracker dye which is a preliminary dye for determining the redox status (Figure 10a). ROS 
production was observed in neutrophils by using carboxy-H2DCFDA (5-(and 6-)carboxy-2',7'-
dichlorodihydrofluorescein diacetate), a reliable fluorogenic marker for reactive oxygen species 
in live cells. ROS production was reduced in neutrophils even when they were activated with 
LPS before treatment with ANG (Figures 12a and 12b). 
3.5.6. ANG induces apoptosis in LPS-activated human neutrophils 
LPS is known to prolong neutrophil survival by delaying their constitutive apoptosis (Aoshiba, 
Yasui et al. 1999). To determine whether ANG induces apoptosis in LPS-activated neutrophils, I 
incubated human neutrophils with LPS with or without ANG pre-treatment and stained them for 
cleaved caspase-3 as an indicator of apoptosis.
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Figure 10a: Localization of reduced mitotracker (in red) and FITC-ANG (in green) in 1µg/ml 
LPS (30 min.) or 1µM fMLP (1 min.) stimulated mouse neutrophils (0.8 X 10
6
 cells/ml) in 
suspension (sus), adhered on fetal bovine serum (FBS) or vitronectin (vitro) coated coverslips. 
Notice attenuation of mitochondrial activation after 12.5µg/ml FITC-ANG pre-incubation. (n=3). 
Please note that merge for the last treatment group i.e. ANG+LPS on vitronectin coated 
coverslips shows merge of DAPI (blue), reduced mitotracker (red) and FITC-ANG (green). 
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Figure 10b: Immunofluorescence of F1F0 ATP synthase  subunit (in fuschia) and reduced 
mitotracker (in red) in LPS (30 min.) stimulated human neutrophils (0.8 X 10
6
 cells/ml) adhered 
on FBS coated coverslips. Note attenuation of signal for ATP synthase as well as reduced 
mitotracker in ANG incubated cells. Arrows indicate expression of F1F0 ATP synthase. (n=3) 
Figure 10c: Fluorescence intensity measurements of F1F0 ATP synthase (fuschia channel) in 
PBS, LPS and ANG+LPS treatment groups as indicated in the confocal experiment described 
above (n=3). Average intensities, for the fuschia channel, from 100 neutrophils per slide were 
measured by Image J software. Statistical differences at p < 0.05 are indicated by asterisks (*). 
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Figure 11a: Immunofluorescence of phosphorylated p38 MAPKinase and phosphorylated 
p42/44 MAPKinase (in red) in PBS or 1µg/ml LPS (30 min.) stimulated mouse neutrophils (0.8 
X 10
6
 cells/ml) adhered on FBS coated coverslips. Note attenuation of the signal in 12.5µg/ml 
ANG incubated cells. (n=3) 
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Figure 11b: Immunofluorescence of phosphorylated p38 MAPKinase (Pp38 MAPK) (in cyan), 
actin (in red) and ANG (in green) in PBS or 1µg/ml LPS (30 min.) stimulated human neutrophils 
(0.8 X 10
6
 cells/ml) adhered on FBS coated coverslips. Note attenuation of the signal in ANG 
incubated cells. (n=3) 
Figure 11c: Expression of Pp38 MAPK in human neutrophil lysates subjected to SDS 
electrophoresis. Neutrophils (2 X 10
6
 cells/ml) were activated with 1 µg/ml LPS for 30 min. 
Note attenuation of p38MAPK in 12.5 µg/ml ANG as well as 500nM SB239063 pre-treated (30 
min.) neutrophils. The graph depicts percent inhibition of the expressed protein where LPS 
represents 100% of the protein. Statistical differences at p < 0.05 are indicated by asterisks (*). 
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Figure 11d: Immunofluorescence of phosphorylated p42/44 MAPKinase (Pp44/42 MAPK) (in 
cyan) and actin (in red) in PBS or LPS (30 min.) stimulated human neutrophils (0.8 X 10
6
 
cells/ml) adhered on FBS coated coverslips. Note attenuation of the signal in 12.5µg/ml ANG 
incubated cells. (n=3) 
Figure 11e: Expression of Pp44/42 MAPK in human neutrophil lysates subjected to SDS 
electrophoresis. Neutrophils (2 X 10
6
 cells/ml) were activated with 1 µg/ml LPS for 30 min. 
Note attenuation of Pp44/42 MAPK in 12.5µg/ml ANG as well as 1µM U0126 pre-treated 
(30min.) neutrophils. The graph depicts percent inhibition of the expressed protein where LPS 
represents 100% of the protein. Statistical differences at p < 0.05 are indicated by asterisks (*). 
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Figure 12a: Localization of reactive oxygen species (ROS) detected by carboxy-H2 DCFDA (in 
green) in 1µg/ml LPS (30 min.) stimulated human neutrophils (0.8 X 10
6
 cells/ml). Note 
attenuation of ROS in 12.5µg/ml ANG incubated cells. (n=3) 
Figure 12b: Fluorescence intensity measurements of carboxy-H2 DCFDA (green channel) in 
PBS, LPS ANG+LPS and LPS+ANG treatment groups as indicated in the confocal experiment 
described above (n=3). Average intensities, for the green channel, from 100 neutrophils per slide 
were measured by Image J software. Statistical differences at p < 0.05 are indicated by asterisks 
(*). 
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Figure 13a: Immunofluorescence of cleaved caspase-3 (in cyan in PBS, 1µg/ml LPS (4 hrs.), 
ANG+LPS or LPS+ANG stimulated human neutrophils (0.8 X 10
6
 cells/ml) adhered on FBS 
coated coverslips. Note activation of cleaved caspase-3 in cytosol of 12.5µg/ml ANG pre- amd 
post-LPS treatments. (n=3). 
Figure 13b: Fluorescence intensity measurements of activated caspase-3 (cyan channel) in PBS, 
LPS ANG+LPS and LPS+ANG treatment groups as indicated in the confocal experiment 
described above (n=3). Average intensities, for the cyan channel, from 100 neutrophils per slide 
were measured by Image J software. Statistical differences at p < 0.05 are indicated by asterisks 
(*). 
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While ANG per se does not induce apoptosis, it stimulated an intense expression of 
activated caspase-3 in LPS-stimulated human neutrophils at a 4 hour time point compared to 
both control and LPS-activated neutrophils (Figures 13a and 13b). Interestingly, ANG induced 
the expression of activated caspase-3 even in those neutrophils that were pre-treated with LPS 
(Figures 13a and 13b). 
3.5.7.  ANG inhibits adhesion and transendothelial migration in TNFα-activated 
cremaster muscle 
Lastly, I did translational evaluation of function of ANG in transendothelial migration of 
leukocytes under flow conditions in cremaster muscle venules. The rolling flux was significantly 
reduced in TNFα group at all time-points compared to the control groups as well as ANG 
treatment groups (Figure 14a). Adhesion and emigration was significantly higher in TNFα group 
compared to all other groups. ANG treatment group had significantly higher number of adhered 
and emigrated cells compared to saline and ANG only groups but was less when compared to 
TNFα group (Figures 14c and 14d). Control groups such as saline or ANG only had significantly 
higher rolling velocity compared to TNFα or ANG treatment groups (Figure 14b). TNFα 
upregulates chemokine expression, produces inflammation in the cremaster muscle with 
significantly lower rolling flux, velocity and a markedly high index of adhesion and emigration 
(Wong, Heit et al. 2010). ANG treatment produces significantly higher rolling flux and velocity 
and a significantly lower adhesion and emigration. H&E data (Figure 15) support my off-line 
video analysis ( Movie 3, 4, 5, 6). The dose of TNFα employed in my studies did not produce 
systemic effects as indicated by similar leukocyte counts in the peripheral blood (data not 
shown). 
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3.6 Discussion 
ANG is upregulated in acute respiratory distress syndrome (Lucas, Lijnen et al. 2002), 
and neutrophils can also produce ANG (Scapini, Nesi et al. 2002). Neutrophils upon activation 
are credited with elimination of bacteria as well as causing significant tissue damage. I provide 
novel data that ANG inhibits neutrophil migration, induces silence by deactivating ROS 
production and activating apoptotic pathway, and inhibits their recruitment iv-vivo.  
ANG does not bind to resting neutrophils but binds to and is endocytosed by fMLP-activated 
neutrophils. ANG co-localized with the lipid raft markers flotillin-1 and flotillin-2 in LPS and 
fMLP stimulated neutrophils. Disruption of lipid rafts with MCD inhibited ANG uptake, 
indicating that ANG binding and internalization are mediated via lipid rafts. β3 integrin, a known 
ligand for ANG, colocalized with ANG in a nonpolar fashion. Integrins can recycle to and from 
lipid rafts during chemotaxis (Hendey, Lawson et al. 1996, Fabbri, Di Meglio et al. 2005). 
Integrin blocking experiments were done to study the interaction of ANG with β3 integrin. 
Unexpectedly, integrin blocking did not prevent ANG endocytosis, but restored polarization of 
neutrophils in the presence of ANG and fMLP. There are three possible explanations for this 
partial reversal of ANG’s effects with blockade of β3¬ integrin. First, LM609 is an allosteric 
inhibitor of αVβ3 integrin but ANG interacts with RGD binding site on this integrin. Second, it 
has been recently shown that integrins are dispensable for neutrophil migration (Lammermann, 
Bader et al. 2008). Based upon lipid raft blocking experiment, I speculate that other membrane 
proteins like flotillin and caveolin-rich microdomains are possibly involved in endocytosis of 
ANG (Fabbri, Di Meglio et al. 2005, Castel, Pagan et al. 2001). Third, ANG and LM609 may not 
be stoichometrically balanced so that the block was not sufficient.
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Figure 14a: Rolling Flux (cells/minute) of leukocytes in post-capillary venules of cremaster 
tissue at 3, 3.5, 4, 4.5 and 5 hours, along X-axis, after intrascrotal injection of saline (n=10), 
ANG (260μg/mice) (n=5), TNFα (0.05μg/mice) (n=9) and TNFα (0.05μg/mice)+ANG 
(260μg/mice) (n=5). Statistical differences at p < 0.05 are indicated by asterisks (*). 
Figure 14b: Rolling velocities (μm/second) of first twenty rolling leukocytes in post-capillary 
venules of cremaster tissue at 3, 3.5, 4, 4.5 and 5 hours, along X-axis, after intrascrotal injection 
of saline (n=10), ANG (260μg/mice) (n=5), TNFα (0.05μg/mice) (n=9) and TNFα 
(0.05μg/mice)+ANG (260μg/mice) (n=5). Statistical differences at p < 0.05 are indicated by 
asterisks (*) and hash (#). 
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Figure 14c: Adhesion (number of cells per 100μm vessel length) of leukocytes in post-capillary 
venules of cremaster tissue at 3, 3.5, 4, 4.5 and 5 hours, along X-axis, after intrascrotal injection 
of saline (n=10), ANG (260μg/mice) (n=5), TNFα (0.05μg/mice) (n=9) and TNFα 
(0.05μg/mice)+ANG (260μg/mice) (n=5). Statistical differences at p < 0.05 are indicated by 
asterisks (*) and hash (#). 
Figure 14d: Emigration (number of cells per field of view i.e. two screens wide) of leukocytes 
above and below the post-capillary venules of cremaster tissue at 3, 3.5, 4, 4.5 and 5 hours, along 
X-axis, after intrascrotal injection of saline (n=10), ANG (260μg/mice) (n=5), TNFα 
(0.05μg/mice) (n=9) and TNFα (0.05μg/mice)+ANG (260μg/mice) (n=5). Statistical differences 
at p < 0.05 are indicated by asterisks (*) and hash (#). 
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Figure 15: Representative differential interference contrast and H&E stained images of 
cremaster tissue hours after after intrascrotal injection of saline (n=10), ANG (260μg/mice) 
(n=5), TNFα (0.05μg/mice) (n=9) and TNFα (0.05μg/mice)+ANG (260μg/mice) (n=5). 
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Figure 16: Schematic diagram for mechanism of action of angiostatin (ANG) in acute 
inflammation. ANG inhibits and adhesion as well as neutrophil trans-endothelial migration in an 
acute inflammation setting by inhibiting the leading edge actin dynamics. Dashed arrows depict 
hypothesized ANG binding to angiomotin (AMOT) that inhibits guanosine triphophate (GTP) 
recycling required for F-actin aggregation at the leading edge, thereby, inhibiting neutrophil 
chemotaxis. Note the apoptotic nuclear morphology (depicted in green) in LPS stimulated 
neutrophil incubated with ANG at a 4hr. time point. For further explanation, refer text. 
68 
Polarisation in response to chemoattractants is a primal event in chemotaxis. Iv-vitro confocal 
microscopy on mouse as well as human neutrophils revealed that ANG abolished polarisation as 
well as activation of neutrophils in response to fMLP and LPS. Hsp-27 induces actin capping and 
phosphorlyation of hsp-27 is essential for maintaining polarised heads (Jog, Jala et al. 2007). 
Immunoprecipitation revealed that hsp-27 binds to both α and β tubulin and inhibits tubulin 
polymerization (Hino, Hosoya 2003, Hino, Kurogi et al. 2000). ANG colocalises with this 
protein and blocked formation of polarized heads. It is however, still unclear if inhibition of hsp-
27 phosphorylation is a direct effect of ANG or due to inactivation of MAPKinases. 
The PDZ domain of AMOT can bind to cdc-42 Rho GTPase Activating Protein (GAP), 
Rich1 and produce a hypermigratory state in endothelial and epithelial cells. p190 Rho GAP is a 
RhoGAP that uncouples GTP from small G-protein Rho in order to recycle the small G-proteins 
during early establishment of polarity (Wells, Fawcett et al. 2006). AMOT is also known to be a 
scaffolding protein for Rich1 in endothelial and epithelial cells (Wells, Fawcett et al. 2006). 
Because of ANG’s colocalization with AMOT and tubulin in human neutrophils, I speculate that 
ANG ultimately interferes with microtubular rearrangement. It has been shown earlier that ANG 
can bind to actin in cultured macrophages and endothelial cells (Dudani, Mehic et al. 2007, Perri, 
Annabi et al. 2007). I found AMOT as a probable candidate for ANG mode of action during 
inhibition of chemotaxis. 
I did not observe co-localization of ATP synthase, another putative ANG binding protein, 
with ANG. However, ANG diminishes ATP synthase expression and the function of 
mitochondria which is in concordance with an earlier observation where ANG upregulates 
antiangiogenic and proapoptotic pathways via mitochondrial proteins (Lee, Muschal et al. 
2009a). Mitochondria aggregate near the plasma membrane, as indicated by flotillin-1 and 
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flotillin-2 co-expression with mitochondria in LPS activated human neutrophils. Mitochondria 
activated by LPS generate ROS through p44/42 MAPKinase phosphorylation (Markvicheva, 
Gorokhovatskii et al. 2010, Espinosa, Leiva et al. 2006, Zhong, Jiang et al. 2003). Respriatory 
burst is also mediated by integrin β3 signalling (Yan, Novak 1999). ANG abolished the ROS 
response in neutrophils possibly through binding to αVβ3 integrin. Downstream molecules for 
chemotaxis regulation are in part mediated by phosphorylation of p38 MAPKinase (Kutsuna, 
Suzuki et al. 2004).  TLR agonists such as endotoxin activate neutrophils to stimulate 
downstream MAPKinase pathways and thus regulate their migration and survival (Sabroe, 
Dower et al. 2005), as well as production of ROS. The produced ROS contribute critically to 
collateral tissue damage in the host. Neutrophil MAPKinase signalling in response to fMLP or 
LPS is silenced by ANG. ANG treatment of neutrophils either before or after the LPS exposure 
abolishes ROS production and induced expression of caspase-3 to limit neutrophil survival.  
Once the iv-vitro effects of ANG were observed in isolated neutrophils, I was interested 
in looking at ANG’s effect on leukocyte migration under flow conditions. ANG inhibits 
leukocyte recruitment in Boyden’s chamber (BENELLI, MORINI et al. 2002). My intravital 
experiments show that ANG also blocks neutrophil adhesion and emigration iv-vivo under flow 
conditions.  
Taken together (Figure 16), the data show that ANG deactivates neutrophils, limits their 
survival and inhibits their iv-vivo migration in inflamed blood vessels. Hypothesis was proven 
true. Based on these data, ANG may act as a novel inhibitor of acute inflammation. 
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CHAPTER 4 
FUNCTION OF ANGIOSTATIN IN ACUTE LUNG INJURY 
4.1. At a Glance Commentary 
The current study shows that subcutaneous angiostatin treatment inhibits neutrophilia and 
fluid accumulation in mice acute lung injury model as assessed by conventional cytological, 
biochemical and histological techniques as well as by novel synchrotron diffraction enhanced 
imaging followed over 9 hours utilising diffraction enhanced imaging. I also show reduced 
neutrophil activation in lung microvessels. As angiostatin treatment does not affect cytokines and 
chemokines analysed by us, but reduces neutrophil infiltration and activation in mice lungs, it 
offers novel inhibition of neutrophil migration during acute lung injury. 
4.2. Abstract 
Rationale: Acute lung injury is marked by profound neutrophil influx along with fluid 
accumulation that impairs lung function at the cost of high mortality. Neutrophils are activated 
and are programmed for anti-apoptosis during this phase in order to be competent phagocytes 
over the next couple of hours. Toxic mediators due to neutrophil over-activation leads to tissue 
damage that in turn impairs lung function. Angiostatin is an endogenous antiangiogenic molecule 
highly expressed in lavage fluid of patients with acute respiratory distress syndrome that has 
recently been shown to inhibit neutrophil infiltration in mice peritonitis. Objective: My aim was 
to investigate the role of angiostatin in acute lung injury. Methods: I used bacterial 
lipopolysaccharide induced acute lung injury model for bronchoalveolar lavage and lung 
analysis. In addition, I imaged mice lungs with synchrotron diffraction enhanced imaging to 
assess lung area and contrast ratios over 9 hours. Measurements and Main Results: Subcutaneous 
angiostatin reduces neutrophil influx, protein accumulation, lung Gr1+ neutrophils and 
myeloperoxidase activity, phosphorylated p38 MAPK without affecting the levels of MIP-1α, 
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IL-1β, KC and MCP-1 in lavage and lung homogenates. Diffraction enhanced imaging shows 
that angiostatin causes a time-dependent improvement in lung area and lung contrast ratios that 
reflect reduction in lung edema. Conclusion: Overall, the study shows that angiostatin is a novel 
inhibitor of acute lung injury in mice. 
Key Words: acute lung injury; angiostatin; DEI 
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4.3. Introduction 
Inflammation is the host response to microbial or chemical stimuli and typically involves 
migration of inflammatory cells such as neutrophils or polymorphonuclear cells (PMNs) in the 
affected organ (Jain, Bellingan 2007, Mizgerd 2008). Acute lung injury is characterized by the 
migration of activated neutrophils into lung vasculature and alveoli (Matute-Bello, Martin 2008, 
Perl, Lomas-Neira et al. 2008). These activated neutrophils live longer and cause significant 
tissue damage through inflammatory products like proteinases, cationic polypeptides, cytokines 
and reactive oxygen species (ROS) (Witko-Sarsat, Rieu et al. 2000, Dallegri, Ottonello 1997, 
Haslett 1999, Haslett, Savill et al. 1989). The paradox of neutrophil biology is highlighted by the 
fact that although activated neutrophils are essential for clearing of bacteria, the tissue damage 
caused by them is believed to be the cause of organ failure, morbidity and mortality. Hence, 
there is a need to understand the processes that regulate neutrophil activation and their lifespan in 
acute lung injury. 
Angiostatin (ANG), a potent anti-angiogenic molecule, is the cleavage product of 
plasminogen and is composed of the either the first four or three-Kringle (K) domains (Wahl, 
Kenan et al. 2005, O'Reilly, Holmgren et al. 1994). K-5 of plasminogen also shows similar 
activity (Lu, Dhanabal et al. 1999). Figure 4 depicts conversion of plasminogen to plasmin, 
reduction of plasmin by phopshoglycerate kinase followed by serine proteinase dependent 
release of Kringle (K) 1-4½ and finally matrix metalloprotease-dependent trimming of K 1-4½ to 
K 1-4 or K1-3 (Lay, Jiang et al. 2000). Proteolysis of membrane-bound plasmin generates 
angiostatic molecules in-vitro and in-vivo (Falcone, Khan et al. 1998). Western blots from 
cutaneous wound model detect ANG forms and plasminogen as early as day 1 and day 3 after 
generation of the wounds (i.e., at the initial phase of wound healing) and expression of ANG 
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forms peaked during the last phase of wound healing, and almost disappeared after wound 
healing was complete (Chavakis, Athanasopoulos et al. 2005). ANG released from PMNs 
mediate the initial angiogenic switch in mouse model of multi-stage carcinoma (BENELLI, 
MORINI et al. 2002, Scapini, Nesi et al. 2002, Nozawa, Chiu et al. 2006). Platelets are also well 
known to produce ANG from uPA (JURASZ, SANTOS-MARTINEZ et al. 2006). 
ANG binds to several cell surface proteins (Wahl, Kenan et al. 2005, Tabruyn, Griffioen 2007) 
such as ATP synthase F1F0, heat shock proteins (hsp) 27 and 70, annexin II (Syed, Martin et al. 
2007, Sharma, Rothman et al. 2006), αVβ3 integrin (Tarui, Miles et al. 2001) and angiomotin 
(Troyanovsky, Levchenko et al. 2001a) to produce anoikis, apoptosis and cell migration. ANG 
binds to adhesion proteins such as integrin αvβ3 expressed on the apical and basal surfaces of 
endothelial and epithelial cells (Singh, Fu et al. 2000). ANG also induces the expression of 
adhesion molecules (ICAM-1, E-selectin) (Luo, Lin et al. 1998, Chen, Huang et al. 2008), and 
through interaction with Mac-1 (αMβ2) integrin as well as reduced activation of NF-κB and 
related tissue factor expression inhibits peripheral blood leukocyte recruitment and angiogenesis 
in a mouse model of acute peritonitis (Chavakis, Athanasopoulos et al. 2005). ANG levels are 
reportedly increased in acute respiratory distress syndrome and septic patients (Hamacher, Lucas 
et al. 2002, Lucas, Lijnen et al. 2002, Singh, Janardhan et al. 2005), which along with high levels 
of TNF- have been implicated in in-vitro endothelial cell cytotoxicity that is indicative of its 
potential role in ARDS-related EC injury (Hamacher, Lucas et al. 2002). These data indicate a 
potential role of ANG in cell activation and inflammation.  
Currently, there are no data on the effects of ANG in acute lung injury. Because increased levels 
of ANG have been reported in the lungs of ARDS and septic patients (Hamacher, Lucas et al. 
2002, Lucas, Lijnen et al. 2002, Singh, Janardhan et al. 2005), I investigated the role of ANG in 
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mouse model of lipopolysaccharide-induced acute lung injury. I also imaged mice lungs with 
diffraction enhanced imaging using synchrotron radiation. Conventional invasive techniques are 
helpful in delineating the molecular mechanism of a pathophysiological event but they do not 
represent the mass dynamics of a disease progression as has been underlined in acute lung injury. 
Dynamic imaging of small lung airways remains a challenge despite wide strides in imaging 
relatively static tissue beds. X-rays are still the only available diagnosis for lung pathologies that 
utilise absorption to highlight the hard tissue from soft tissue. However, this does not resolve soft 
tissues like lungs. The unique properties of synchrotron radiation, in particular its brightness, 
make synchrotron radiation ideal for these experiments. With this configuration and a high-speed 
detector, it is possible to acquire dynamic images with relative ease. Diffraction Enhanced 
Imaging (DEI) derives contrast from an object’s X-ray absorption, refraction gradient and small 
angle scatter properties (extinction) (Chapman, Pisano et al. 1998, Chapman, Nesch et al. 2006, 
Chapman, Thomlinson et al. 1997). 
4.4. Materials and Methods 
All the animal experiments were conducted in accordance with the institutional 
guidelines and following approval from the University of Saskatchewan Animal Ethics Board. 
Six to eight weeks old male C57BL6 mice purchased from Animal Resource Center of the 
University of Saskatchewan. E. coli 0127:B8 lipopolysaccharide (LPS; Sigma Chemicals, St. 
Louis, MO, USA), ANG K1-4 (Haematologic Technologies Inc., Essex Junction, VT, USA), 
mouse Ly-6G Ly-6C (Gr-1) antibody (BD Biosciences, San Jose, CA, USA), human vWF, 
secondary anti-rat and anti-rabbit HRP (horseradish peroxidase) conjugated antibody (Dako, 
Carpinteria, CA, USA), Vector
®
 VIP peroxidase substrate kit (Vector Laboratories, Burlingame, 
CA, USA) were purchased commercially. 
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Experiment Design
Group N Treatment I - 0hr Treatment II - 5hr
I 5 Saline Saline
II 5 Saline i.v. ANG (20 mg/kg)
III 5 Saline s.c. ANG (20 mg/kg)
IV 8 LPS (80 μg/80 μl) Saline (80 μl)
V 6 LPS (80 μg/80 μl) i.v. ANG (20 mg/kg)
VI 6 LPS (80 μg/80 μl) s.c. ANG (20 mg/kg)
0 hr 5 hr 9 hr
Intranasal 
LPS or 
saline
ANG or saline injection Euthanise
peripheral blood, 
BAL and lung tissues
 
Figure 17: Experimental protocol indicating the design of six treatment groups.
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4.4.1. Intranasal LPS-Induced Mouse Acute Lung Injury Model 
I used an intra-nasal LPS instillation mouse model of acute lung inflammation (Szarka, 
Wang et al. 1997). The angiostatin post-treatment protocol and dose were standardized after a 
series of preliminary experiments and the treatment groups are shown in Figure 17. Peripheral 
blood was collected through cardiac puncture for differential and total peripheral leukocyte 
counts, and lungs were lavaged with a total of 1.5 ml of ice-cold Hank’s balanced salt solution 
(HBSS). The right lung bronchus was ligated and fixed the left lung in-situ with four percent 
paraformaldehyde (PF) for one hour after which the right lung was snap frozen. 
4.4.2. Bronchoalveolar Lavage (BAL) 
BAL was centrifuged at 700g (2500 rpm) and supernatant stored at -80°C for protein 
estimation and cytokine assay. Cells were resuspended at 10
6
/ml to make cytospin for differential 
count. 
4.4.3. Peripheral Blood Leukocyte counts 
Total and differential leukocyte counts (TLC and DLC) were done after RBC hemolysis 
with 2% acetic acid and blood smear stained with Diffquick
®
.  
4.4.4. Lung MPO Assay  
Lung homogenates were centrifuged in 50 mM HEPES (pH 8.0) at 900g (3000 rpm) for 
20 minutes at 4°C. The pellet was resuspended in 0.5% CTAC (cetyl trimethylammonium 
chloride) solution and rehomogenised. MPO colorimetric assay was performed (Schierwagen, 
Bylund-Fellenius et al. 1990) using 3,3´,5,5´-tetramethylbenzidine (TMB) as substrate for H2O2 
under low pH conditions. Results were expressed as MPO units per mg of lung tissue. 
4.4.5. Protein assay  
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Bradford’s reagent was used to assess total lung as well as BAL protein (Bio-Rad, 
Hercules, CA, USA).  
4.4.6. Cytokine assay   
Sandwich ELISA was performed on lung homogenates for MCP-1 (monocyte 
chemoaatractant protein-1), KC (keratinocyte chemoattractant), IL-1 (interleukin-1 beta), MIP-
1 (macrophage inflammatory protein-1 alpha) using ELISA kits from R&D systems, US. 
4.4.7. Lung H&E Staining  
The OCT embedded left lung was cut into four micron sections and stained with 
hematoxylin and eosin to assess structural changes in various groups. 
4.4.8. Anti-Gr-1 and Phosphorylated p38 MAPK Immunohistochemistry 
             Briefly, cryosections were subjected to endogeneous peroxide removal followed by 
antibody blocking, primary rat anti-mouse Gr-1 or anti-phosphop38MAPK and secondary anti-
rat HRP conjugated antibody treatments. Negative controls and positive controls were included 
for every section that comprised of no primary antibody and vWF (von Willbrand factor) stain, 
respectively. Semi-quantitative scoring (0 = no staining; 1 = light staining; 2 = moderate 
staining; and 3 = heavy staining) was performed on five sections/treatment group.  
4.4.9. Western Blots 
                Lung homogenates were processed to detect plasminogen and ANG proteins. Briefly, 
homogenates extracted with equal volume of 2X Laemmli Sample Buffer Concentrate (Sigma) 
were electrophoresed in 12% SDS-PAGE at 180V followed by electro-transferred to 
nitrocellulose membranes at 100V for 60 minutes. The resulting membranes were, thereafter, 
blocked (5% skim milk in 0.1% PBS-T for 60 minutes), incubated with rat monoclonal 
plasminogen antibody (ab61387) overnight at four degrees, washed three times with PBS-T for 5 
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minutes each and exposed to HRP-conjugated anti-rat IgG antibody for 60 minutes. The 
membrane was treated with ECL (enhanced chemiluminescence system) solutions (GE 
Amersham Western Blotting Detection Reagents) and developed with special ECL sensitive 
films (GE, UK). The probed membranes were restored with blot-restore solution (Millipore, CA, 
US) to be re-probed with β-actin that served as a house-keeping gene product. The blots were 
subjected to densitometric quantification.  
4.4.10. DEI Imaging  
For DEI imaging, mice were mounted vertically on a custom-made plexiglass board and 
monitored from the control room during imaging. Exposure times per frame for phase contrast 
imaging 1 s corresponding to a surface entrance dose of approximately 1Gy per frame.  
For the DEI imaging the scans took approximately 50 seconds with a total dose per scan of about 
0.4mGy (about 1/10 of a mammogram exposure). Lungs were imaged at the synchrotron facility 
of Canadian Light Source at University of Saskatchewan, Canada on beamline BMIT. A Si 
(2,2,0) double-crystal monochromator  was used to select a narrow bandwidth of the bending 
magnet radiation. 16.5 keV x-rays were chosen to provide both good phase and absorption 
contrast from the mice lungs. All objects were positioned in hutch POE-2 of beamline BMIT, 
approximately 24 m downstream of the synchrotron source. The Si (4,4,0) planes were used in 
the double crystal monochromator to select 40keV with a matching Si (4,4,0) analyzer after the 
object, but before the detector.  Photonic Science detector XDR-90 (Photonic Science, UK) was 
placed 3.0 m downstream.  This detector had 18.7micron square pixel size with a field of view of 
approximately 50mm (horizontal) x 75mm (vertical).  Images on both sides of the rocking curve 
as well as on top of the curve were recorded. Images were recorded at 2 hr intervals for 9 hrs 
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with a Hamamatsu phosphor charge-coupled device (CCD) camera (C9300-124). At the end of 
imaging, mice were euthanized for collection of lungs and stained them with H&E. 
4.4.11. DEI Image Analysis 
               Following image acquisition, ImageJ software (National Institutes of Health; 
rsbweb.nih.gov/ij/) was used to correct for dark current and non-uniform beam intensity effects. 
This was achieved by the usual method of recording a flat field with identical illumination to the 
experimental image but with no object and a dark image with the x-ray shutter closed. Identical 
exposure times were used for the experimental and the correction images. Both the experimental 
image and the flat field image were first corrected by subtracting the dark image and then the 
dark corrected experimental image was divided by the dark corrected flat field image. 
Normalized DEI images were further processed for calculation of percent increase in lung area 
(cm
2
) and in contrast ratios of top images w.r.t. respective 0 hr images. 
4.5. Statistical Analysis 
Results were analysed by application of one-way ANOVA and unpaired t-test to assess 
differences between two groups followed by Bonferroni’s all group comparison utilizing 
Graphpad software. The treatment significance was set at P< 0.05. 
4.6 Results 
4.6.1. BAL Cell Counts 
LPS caused a significant rise in BAL total as well as neutrophil cell counts (Figures 18a 
and 18d). Intravenous ANG treatment of LPS-treated mice resulted in significant increase in 
BAL leukocytes compared to the LPS only group.  However, the subcutaneous treatment of LPS-
treated mice with ANG significantly reduced the numbers of neutrophils in the BAL (Figure 
18a). Subcutaneous ANG treatment of LPS-challenged mice caused a significant increase in 
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apoptotic neutrophils in their BAL (Figure 18c) compared to the LPS and LPS+ANG 
intravenous groups. Mice treated with only ANG, irrespective of the route, did not alter the BAL 
cell counts, which were primarily comprised of alveolar macrophages (Figure 18a). 
4.6.2. BAL Protein  
BAL protein concentration, as an indicator of vascular permeability, was increased in LPS-
treated mice (343.711.3 μg/ml) compared to saline treatment (15642.8 μg/ml). The 
subcutaneous but not intravenous ANG treatment caused a significant reduction in protein 
concentration (303.415.7 μg/ml) compared to the LPS-treated mice (Figure 18b). All LPS 
groups had significantly higher protein concentration compared to the control groups (saline 
only, intravenous ANG only and subcutaneous ANG only). 
4.6.3. Peripheral Blood Leukocyte counts 
While TLC didn't differ among treatment groups, monocytes were decreased and 
neutrophils were increased in all the LPS-challenged animals compared to the negative controls 
(Figure 19). 
4.6.4. Lung MPO Assay 
MPO, a surrogate indicator of neutrophils, was significantly lower in the saline group 
compared to all LPS treatments irrespective of the ANG treatments (Figure 20). However, LPS-
challenged mice treated with ANG, both subcutaneous and intravenous, showed significantly 
lower MPO compared to the LPS only animals. 
4.6.5. Anti-Gr-1 Immunohistochemistry 
To evaluate the neutrophils still trapped in the lung tissues, I stained lung sections with 
Gr-1 antibody. Figure 22a shows clear airways and alveolar septa whereas in figure 22b intense 
staining for neutrophils is seen in perivascular, peribronchiolar areas along with alveolar septa of 
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the LPS-treated mice. Figures 21c and 21d represent the LPS + intravenous ANG and LPS + 
subcutaneous ANG treatments, respectively, and show moderate degree Gr-1 staining mainly in 
alveolar septa. I was able to obtain a similar trend of Gr-1 staining in immunohistochemical 
slides (Figure 21e). vWF staining, normally used as an immunohistochemical control (Figure 
22b) showed marked increase in the lungs from LPS+ intravenous ANG group. 
4.6.6. Expression of IL-1, MIP-1, MCP-1 and KC  
I assayed IL-1, MIP-1, MCP-1 and KC in BAL for their well-established roles in ALI 
and found them to be significantly increased in LPS-treated groups compared to saline treatment 
(Figure 23). However, there were no differences among the LPS-treated animals with or without 
ANG, irrespective of the administration route. Also, mRNA levels of these cytokines and 
chemokines in lung tissue were not different among endotoxin-treated animals (Figure 24). 
4.6.7. Lung H&E Staining 
Lung sections from the saline group showed normal alveolar septa (Figure 25a) while 
those from the LPS-treated mice had septal congestion, and neutrophil accumulation in the septa 
and the perivascular and peribronchial areas (Figure 25b). Compared to the lungs sections from 
the LPS + intravenous ANG mice (Figure 25c), those from subcutaneous ANG+ LPS mice 
contained markedly reduced lung inflammation (Figure 25d). Although all the lungs were 
lavaged, I still observed neutrophils in the alveoli of lung sections from the LPS and 
LPS+intravenous ANG mice that indicate robust migration of neutrophils.  Mice treated with 
only ANG, either intravenous or subcutaneous, show normal lung histology similar to the saline 
only group.  
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4.6.8. Phosphorylated p38 MAPK Immunohistochemistry  
Lung sections from all of the LPS- treated mice showed staining in leukocytes trapped in 
the alveolar septae and blood vessels (Figure 26). 
4.6.9. Western Blots 
Plasminogen bands at 105kDa were detected in all groups. ANG forms were detectable in 
LPS-treated lung homogenates as well as BAL (Figures 27a, 27b). Densitometry showed a forty 
fold increase in ANG expression in LPS-treated lavage samples (Figure 27a) and a tenfold 
increase in corresponding lung homogenates compared to saline treated samples (Figure 27b). 
4.6.10. DEI Imaging 
Figure 28 shows absorption (top) images of mice lung. Due to fewer animals used, I 
discuss trends observed across groups over time. Increase in lung area is an index of increased 
lung weight due to edema following endotoxin instillation. Saline treated mice lungs do not gain 
in area over time when compared to 40% increase in LPS treated mice (Figure 29a). 
Subcutaneous ANG treatment at 5 hrs attenuates increase in lung area. 
Contrast ratios are proportional to the light scattered by lungs and therefore reflect number of air-
filled alveoli. The contrast ratios for LPS treated mice lungs show a low percent increase over 
time, with a maximum of 138% (Figure 29b) when compared to LPS + subcutaneous ANG 
treated mice, with a rapid increase to a maximum of 447% (Figure 29b). The lower contrast 
ratios for LPS mice are explained due to lesser number of air-filled alveoli due to fluid 
accumulation that leads to lesser scatter. 
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Figure 18: Bronchoalveolar lavage (BAL) a) total leukocyte counts, b) BAL protein content 
(µg/ml), c) BAL apoptotic PMNs and d) BAL Mature PMNs in the six treatment groups. 
Statistical differences at p < 0.05 are indicated by asterisks (*) and open triangles (Δ). 
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Figure 19: Peripheral blood total and differential leukocyte counts in the six treatment groups. 
Statistical differences at p < 0.05 are indicated by asterisks (*). 
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Figure 20: Lung MPO per unit gram of lung protein in the six treatment groups. Statistical 
differences at p < 0.05 are indicated by asterisks (*). 
86 
 
a b 
c d 
 
Figure 21: 10X magnified Gr-1 stained sections from lavaged lungs in a) control saline treated 
mice show almost negative Gr-1 immunostaining while b) shows signs of heavy staining and 
hence acute inflammation in LPS treated animals after 9 hours. c) shows moderate staining after 
LPS and ANG intravenous treatment whereas d) also shows moderate staining of lung after LPS 
and ANG subcutaneous treatment. 
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Figure 21e: Semiquantitative representation of Gr-1 lung immunohistochemical staining in the 
six treatment groups. Statistical differences at p < 0.05 are indicated by asterisks (*). 
0 = no staining; 1 = light staining; 2 = moderate staining; and 3 = heavy staining 
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   Negative Control Positive Control
vWF Stain in LPS + ANG i.v.
a b 
c 
 
Figure 22: a) vWf stained 10X magnified mice lung sections used as positive control b) Primary 
antibody excluded to serve as a negative control for IHC protocol c) vWf staining in LPS + 
intravenous Angiostatin group. Note the bead like structures that are probably platelets in this 
group and excessive vWf staining indicating damage to the vessel. 
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Figure 23: Lavage cytokine and chemokine concentrations in the six treatment groups. 
Statistical differences at p < 0.05 are indicated by asterisks (*). 
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Figure 24: Lung cytokine and chemokine mRNA fold change in the six treatment groups. 
Statistical differences at p < 0.05 are indicated by asterisks (*). 
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 a b 
c d 
 
Figure 25: 10X magnified hematoxylin-eosin stained sections from lavaged lungs in a) control 
saline treated mice show normal histology while b) shows signs of acute inflammation in LPS 
treated animals after 9 hours c) shows signs of acute inflammation after LPS and ANG treatment 
whereas d) shows near normal looking lung after LPS + ANG subcutaneous treatment. 
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LPS + ANGLPS
BV
 
Figure 26: 10X magnified phospho-p38 MAPK stained sections from lavaged lungs in a) LPS 
treated mice show positive immunostaining in leukocytes trapped in the alveolar septae as well 
as in blood vessel (BV) while b) Subcutaneous ANG treated lung section shows no signs of 
staining . Arrows indicate positively stained leukocytes in LPS treated mice lung section. 
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a 
b 
 
Figure 27: Representative western blots of plasminogen and angiostatin isoforms and 
densitometric analysis for 50kDa ANG in a) lung homogenates and b) bronchoalveolar lavage 
fluid. Also shown corresponding beta-actin expression. Y-axis represents fold difference 
normalized for actin expression. Statistical differences at p < 0.05 are indicated by asterisks (*). 
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Figure 28: Representative normalized DEI images, taken on top of the rocking curve, of saline, 
LPS and LPS + ANG treated mice lungs followed over 9hrs. 
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Figure 29a: Percent increase in lung area of DEI images from saline, LPS and LPS + 
subcutaneous ANG treated mice lungs followed over 9 hrs. 
 
 
Figure 29b: Percent increase in contrast ratios of DEI images from saline, LPS and LPS + 
subcutaneous ANG treated mice lungs followed over 9 hrs. 
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4.7. Discussion 
I report the first data on the anti-inflammatory role of ANG in a mouse model of acute 
lung injury. The data show that subcutaneous but not intravenous treatment with ANG reduces 
histologic signs of lung inflammation, decreases neutrophil migration into the lungs and edema 
formation. ANG reduced leukocyte expression of p38 MAPK. These data are of significance 
because of the critical double-edged role of neutrophils in acute lung injury and because of lack 
of any major therapeutic breakthroughs for ALI. 
I used a well-established model of LPS-induced lung inflammation. The intranasal instillation of 
E. coli LPS resulted in significant increase in leukocytes in BAL and the lung tissues. The 
subcutaneous ANG treatment of the LPS-treated mice caused a significant reduction in 
neutrophil numbers in the BAL and reduced MPO concentrations in lung homogenates. 
Histologically, there was reduced septal congestion and near absence of inflammatory cells in the 
perivascular and peribronchial areas of the LPS + subcutaneous ANG mice compared to the LPS 
only group. In contrast, the intravenous ANG treatment of the LPS-treated mice caused an 
increase in BAL neutrophil numbers compared to the LPS group. The reasons for these strikingly 
different outcomes with subcutaneous and intravenous treatments with ANG are not known and 
were not investigated in my experiments. I do speculate, however, that the differences could be 
due to preferences in the uptake and metabolism of ANG or robust binding to its receptors on 
various vascular cells. Interestingly, mice treated with ANG only irrespective of the route did not 
induce lung inflammation or migration of neutrophils into the lung. Nevertheless, significant 
reduction of neutrophil migration and lung tissue inflammation by ANG is an important 
observation. 
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Neutrophil migration is induced through a complex interplay of adhesion molecules, 
cytokines and chemokines (Ley, Laudanna et al. 2007). Chemokines such as KC, MCP-1 and 
MIP-1 are known mediators of neutrophil migration in the lung (Wagner, Roth 2000) while IL-
1β is a major player in the LPS-induced lung inflammation. While LPS treatment of mice 
resulted in significant increase in the concentrations of these mediators, there was no effect of 
ANG administration on their expression. ANG attenuated p38 MAPK phosphorylation in 
leukocytes in spite of its lack of effect on cytokines and chemokines analysed in this study. 
These data suggest that ANG does not affect neutrophil migration through inflammatory 
molecules analysed in this study. Further LPS + intravenous ANG group shows a distinct 
staining pattern for vWF that is marked by long strings surrounded by beaded structures, 
probably platelets. A recent report shows such binding of integrin v3 to vWF under sheer 
stress (Huang, Roth et al. 2009a). Platelet activation can induce neutrophil recruitment in acute 
lung injury that might be the case in LPS + intravenous ANG group (Andonegui, Bonder et al. 
2003, Clark, Ma et al. 2007, Andonegui, Kerfoot et al. 2005). It is possible that ANG shows its 
effects through direct binding to one of the ligands such as integrin v3, which is expressed by 
neutrophils and endothelial cells in the normal and the inflamed lungs (Singh, Fu et al. 2000, 
Janardhan, Appleyard et al. 2004). In LPS + intravenous ANG group it is possible that ANG 
quickly binds to endothelial cells due to mode of its administration. There is speculation that 
integrin v3 may play a role in neutrophil migration in the lung; however, direct evidence is yet 
to emerge. Based on my unpublished data, ANG may block integrin v3 to inhibit actin 
aggregation to interfere with neutrophil motility in acute lung injury. However, this still may not 
explain the differential effects of subcutaneously versus intravenously administered ANG. This 
discrepancy in BAL neutrophil counts and lung MPO levels might be attributed to more cells 
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getting trapped in the pulmonary capillaries in the subcutaneous group avoiding their 
transmigration in the alveolar spaces. ANG does increase the expression of ICAM-1 and E-
selectin (Luo, Lin et al. 1998, Chen, Huang et al. 2008) that might cause neutrophils to be 
trapped at the endothelial membrane. ANG binds to and inhibits F1F0 ATP synthase under 
conditions of low pH to cause ATP deficiency and consequently caspase-mediated apoptosis 
(Wahl, Kenan et al. 2005, Veitonmäki, Cao et al. 2004). Moreover, neutrophils express ATP synthase 
mRNA (BENELLI, MORINI et al. 2002). Unpublished data from our laboratory have also 
shown attenuation of F1F0 ATP synthase in ANG+LPS treated neutrophils in-vitro along with an 
enhanced apoptosis as witnessed by induction of activated caspase-3. Therefore, apoptotic 
neutrophils observed in ANG treated LPS animals could be attributed to inhibition of ATP 
synthase. A recent study has shown that ANG does not suppress spontaneous apoptosis by 
activating prosurvival pathways in neutrophils but it is yet to be tested if ANG induces 
neutrophil apoptosis by itself (Pluskota, Soloviev et al. 2008). My study also establishes a 
significantly higher expression of ANG in acute lung injury as depicted by western blots of 
lavage fluid and lung homogenates. 
These experiments were my first attempt to visualize live mice lungs under normal or 
inflamed conditions over a span of 9 hrs. Lung area is proportional to lung weight and therefore 
an increase in area reflects increase in lung weight due to edema. ANG treatment attenuates 
increase in lung area that is increased in LPS treated mice. The DEI images obtained over both 
sides of the rocking curve are indicative of the scatter produced by lungs. Therefore, in future I 
would like to go further down the rocking curve in order obtain a fuller description of the ultra-
small angle x-ray scattering (USAXS).  This scattering is a metric of the projected number of air 
filled alveoli.  Thus, a larger amount of scatter implies a larger number of air filled alveoli.  This 
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scatter is reflected in the width of the scattering distribution measured with DEI.  To obtain good 
scatter width information then requires that more images should be taken as a function of rocking 
angle.  This subtle fact was not discovered until after the experimental run was completed. 
Contrast ratios of top images are proportional to the number of air filled alveoli. Therefore, LPS 
treatment causes attenuates any increase in contrast ratios when compared to basal line lungs or 
ANG treated lungs. These findings indicate that ANG causes improvement in lung function over 
time. 
Conclusion 
Hypothesis was proven true. To conclude, it can be stated that ANG, when administered 
through the subcutaneous route, diminishes neutrophilia whereas the intravenous route enhances 
this. From the result of lung myeloperoxidase and granulocyte specific staining, it seems that 
ANG inhibits the transmigration step of neutrophil migration rather than rolling and activation. 
ANG also shuts down leukocyte activation in lung sections as indicated by phospho-p38 MAPK 
immunohistochemistry. However, ANG does not affect cytokine release. ANG also improves 
lung function and edema over time as assessed by DEI.  
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Chapter 5 
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
5.1. General Discussion 
The main aim of my research was to investigate the function of ANG in neutrophil 
migration during ALI. Therefore, my experiments were designed to investigate the effect of 
ANG on neutrophil chemotaxis and activation, leukocyte migration under flow conditions and in 
LPS- induced ALI. The data reported in this thesis advance our knowledge about the ways to 
modulate neutrophil biology in inflamed tissues and also allude to the use of new imaging 
modalities to observe dynamics of lung inflammation. 
ANG is upregulated in acute respiratory distress syndrome (Lucas, Lijnen et al. 2002), 
and neutrophils can also produce ANG (Scapini, Nesi et al. 2002). Neutrophils upon activation 
are credited with elimination of bacteria as well as causing significant tissue damage. The 
complexity however arises from the ability of excessive migration of activated neutrophils into 
an organ to protect the host but causation of tissue damage through production of ROS and 
cytotoxic molecules. The in-vitro study provides novel data that ANG inhibits neutrophil 
migration, induces silence by deactivating ROS production and activating apoptotic pathway, 
and inhibits their recruitment in-vivo. 
To explore the molecular actions of ANG on neutrophils, first I developed a method 
through the use of FITC-NG to image ANG uptake by neutrophils. ANG does not bind to resting 
neutrophils but binds to and is endocytosed by fMLP-activated neutrophils. ANG co-localized 
with the lipid raft markers flotillin-1 and flotillin-2 in LPS and fMLP stimulated neutrophils. 
Disruption of lipid rafts with MCD inhibited ANG uptake, indicating that ANG binding and 
internalization are mediated via lipid rafts. 3 integrin, a known ligand for ANG, colocalized 
with ANG in a nonpolar fashion. Integrins can recycle to and from lipid rafts during chemotaxis 
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(Hendey, Lawson et al. 1996, Fabbri, Di Meglio et al. 2005). Integrin blocking experiments were 
done to study the interaction of ANG with 3 integrin. Unexpectedly, integrin blocking did not 
prevent ANG endocytosis, but restored polarization of neutrophils in the presence of ANG and 
fMLP. The data show that the integrin may not be the only receptor responsible for the uptake 
and actions of ANG in neutrophils. 
Polarisation in response to chemoattractants is a primal event in chemotaxis and entails 
intimate reorganization of cytoskeleton. In-vitro confocal microscopy on mouse as well as 
human neutrophils revealed that ANG abolished polarisation as well as activation of neutrophils 
in response to fMLP and LPS. Hsp-27 induces actin capping and phosphorlyation of hsp-27 is 
essential for maintaining polarised heads (Jog, Jala et al. 2007). Immunoprecipitation revealed 
that hsp-27 binds to both  and  tubulin and inhibits tubulin polymerization (Hino, Hosoya 
2003, Hino, Kurogi et al. 2000). ANG colocalises with this protein and blocked formation of 
polarized heads. It is however, still unclear if inhibition of hsp-27 phosphorylation is a direct 
effect of ANG or due to inactivation of MAPKinases. 
The PDZ domain of AMOT can bind to cdc-42 Rho GTPase Activating Protein (GAP), 
Rich1 and produce a hypermigratory state in endothelial and epithelial cells. p190 Rho GAP is a 
RhoGAP that uncouples GTP from small G-protein Rho in order to recycle the small G-proteins 
during early establishment of polarity (Wells, Fawcett et al. 2006). AMOT is also known to be a 
scaffolding protein for Rich1 in endothelial and epithelial cells (Wells, Fawcett et al. 2006). 
Because of ANG’s colocalization with AMOT and tubulin in human neutrophils, I speculate that 
ANG ultimately interferes with microtubular rearrangement. It has been shown earlier that ANG 
can bind to actin in cultured macrophages and endothelial cells (Dudani, Mehic et al. 2007, Perri, 
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Annabi et al. 2007). I found AMOT as a probable candidate for ANG mode of action during 
inhibition of chemotaxis. 
While ANG didn't co-localize with ATP synthase, it diminished ATP synthase expression 
and the function of mitochondria which is in concordance with an earlier observation where 
ANG upregulates antiangiogenic and proapoptotic pathways via mitochondrial proteins (Lee, 
Muschal et al. 2009a). Mitochondria aggregate near the plasma membrane, as indicated by 
flotillin-1 and flotillin-2 co-expression with mitochondria in LPS activated human neutrophils. 
Mitochondria activated by LPS generate ROS through p44/42 MAPKinase phosphorylation 
(Markvicheva, Gorokhovatskii et al. 2010, Espinosa, Leiva et al. 2006, Zhong, Jiang et al. 2003). 
Respriatory burst, mediated by integrin 3 signalling (Yan, Novak 1999), was abolished by ANG 
possibly through binding to V3 integrin. Downstream molecules for chemotaxis regulation, 
ROS production and lifespan are in part mediated by phosphorylation of p38 MAPKinase 
(Kutsuna, Suzuki et al. 2004), which are activated by LPS. ANG inhibited MAPK signaling in 
activated neutrophils to abolishe ROS production and induced expression of caspase-3 to limit 
neutrophil survival.  
The in-vivo studies are the first data on the anti-inflammatory role of ANG in a mouse 
model of acute lung injury. The data show that subcutaneous but not intravenous treatment with 
ANG reduces histologic signs of lung inflammation, decreases neutrophil migration into the 
lungs and edema formation. ANG reduced leukocyte expression of p38 MAPK. Based on the in 
vitro data and the reduced leukocyte expression of p38MAPK, I believe that ANG inhibits 
leucocyte cytoskeletal rearrangement and other downstream effects through blocking of 
p38MAPK. Although I don't have direct evidence, but based on the endothelial and neutrophil 
expression of integrin αvβ3, it is possible that ANG uses the integrin as a receptor. The precise of 
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role of interaction of the integrin with ANG may be explored through the use of β3
-/-
 mice. The 
direct physical interaction of ANG with one of its receptors and effects on cytoskeletal 
rearrangement may be the reason for reduced neutrophil migration in inflamed lungs because the 
concentrations of measured cytokines and chemokins were not altered by ANG treatment. An 
intriguing observation was that the intravenous ANG treatment of the LPS-treated mice caused 
an increase in BAL neutrophil numbers compared to the LPS group. The reasons for these 
strikingly different outcomes with subcutaneous and intravenous treatments with ANG are not 
known and were not investigated in my experiments. I do speculate however that the differences 
could be due to preferences in the uptake and metabolism of ANG or robust binding to its 
receptors on various vascular cells. Further LPS + intravenous ANG group shows a distinct 
staining pattern for vWF that is marked by long strings surrounded by beaded structures, 
probably platelets. A recent report shows such binding of integrin v3 to vWF under sheer 
stress (Huang, Roth et al. 2009b). Platelet activation can induce neutrophil recruitment in acute 
lung injury that might be the case in LPS + intravenous ANG group (Andonegui, Bonder et al. 
2003, Clark, Ma et al. 2007, Andonegui, Kerfoot et al. 2005). Interestingly, mice treated with 
ANG only irrespective of the route did not induce lung inflammation or migration of neutrophils 
into the lung. Nevertheless these data are of significance because of the critical double-edged 
role of neutrophils in acute lung injury and because of lack of any major therapeutic 
breakthroughs for ALI. 
It is possible that ANG shows its effects through direct binding to one of the ligands such 
as integrin v3, which is expressed by neutrophils and endothelial cells in the normal and the 
inflamed lungs (Singh, Fu et al. 2000, Janardhan, Appleyard et al. 2004). In LPS + intravenous 
ANG group it is possible that ANG quickly binds to endothelial cells due to mode of its 
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administration. There is speculation that integrin v3 may play a role in neutrophil migration in 
the lung; however, direct evidence is yet to emerge. Based on in-vitro data from the first study, 
ANG may block integrin v3 to inhibit actin aggregation to interfere with neutrophil motility in 
acute lung injury. However, this still may not explain the differential effects of subcutaneously 
versus intravenously administered ANG. This discrepancy in BAL neutrophil counts and lung 
MPO levels might be attributed to more cells getting trapped in the pulmonary capillaries in the 
subcutaneous group avoiding their transmigration in the alveolar spaces. ANG does increase the 
expression of ICAM-1 and E-selectin (Luo, Lin et al. 1998, Chen, Huang et al. 2008) that might 
cause neutrophils to be trapped at the endothelial membrane. ANG binds to and inhibits F1F0 
ATP synthase under conditions of low pH to cause ATP deficiency and consequently caspase-
mediated apoptosis (Wahl, Kenan et al. 2005, Veitonmäki, Cao et al. 2004). Moreover, 
neutrophils express ATP synthase mRNA (BENELLI, MORINI et al. 2002). Therefore, 
apoptotic neutrophils observed in ANG treated LPS animals could be attributed to inhibition of 
ATP synthase. A recent study has shown that ANG does not suppress spontaneous apoptosis by 
activating prosurvival pathways in neutrophils but it is yet to be tested if ANG induces 
neutrophil apoptosis by itself (Pluskota, Soloviev et al. 2008). My study also establishes a 
significantly higher expression of ANG in acute lung injury as depicted by western blots of 
lavage fluid and lung homogenates. 
The synchrotron experiments were my first attempt to visualize live mice lungs under 
normal or inflamed conditions over a span of 9 hrs. My intital results of DEI image analysis 
show an improvement in lung congestion produced by subcutaneous ANG treatment as indicated 
by a decrease in lung area and an increase in contrast ratio over 9 hours. The DEI images 
obtained over both sides of the rocking curve are indicative of the scatter produced by lungs. 
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Therefore, in future, I would like to go further down the rocking curve in order obtain a fuller 
description of the ultra-small angle x-ray scattering (USAXS).  This scattering is a metric of the 
projected number of air filled alveoli.  Thus, a larger amount of scatter implies a larger number 
of air filled alveoli.  This scatter is reflected in the width of the scattering distribution measured 
with DEI.  To obtain good scatter width information then requires that more images should be 
taken as a function of rocking angle.  This subtle fact was not discovered until after the 
experimental run was completed. Certainly, DEI has the capacity to quantitatively image lungs 
over time non-invasively; a property that makes this experimental approach unique. 
Conventional invasive techniques are helpful in delineating the molecular mechanism of a 
pathophysiological event but they do not represent the mass dynamics of a disease progression as 
has been underlined in acute lung injury. Further scope of improvement for phase contrast 
imaging lies in changing the object to detector distance in order to optimize the speckle pattern 
of lung images. High radiation dose is a limiting factor in high resolution phase contrast imaging 
coupled with a complicated post-analysis of the speckle pattern. This leaves DEI as a promising 
technique for real-time lung imaging. 
5.2. Conclusions and Future Directions 
Taken together my in-vitro experiments have established (Figure 15) that ANG 
deactivates neutrophils, limits their survival and inhibits in-vivo migration of leukocytes in 
inflamed blood vessels. Based on these data, ANG may act as a novel inhibitor of acute 
inflammation.  
The in-vivo studies show that ANG, through subcutaneous route, diminishes neutrophilia 
whereas the intravenous route enhances this. From, the result of lung myeloperoxidase and 
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granulocyte specific staining, it seems that ANG inhibits the transmigration step of neutrophil 
migration rather than rolling and activation. ANG also shuts down the leukocyte activation in 
lung sections as indicated by phospho-p38 MAPK staining. However, ANG does not affect 
cytokine release. I have standardized the protocol for DEI imaging of mice lungs in ALI. My 
study offers promising non-invasive evaluation of alveolar dynamics in real-time. However, 
there is need to take images further down the rocking curve in order to establish metrics between 
scatter produced by lungs and the number of air-filled alveoli. Therefore, the proposed 
hypotheses were proven true. 
In the present studies, co-localization experiments have indicated possible binding sites 
with tubulin and v3 integrin but these do offer conclusive evidence. Therefore, there is a need 
to direct future studies in order to elucidate the binding proteins of ANG in neutrophils. For 
future experiments, it would be interesting to first look at real-time uptake of FITC-ANG in 
cremaster vascular bed. Based upon the cells that take up ANG in-vivo, the next experiment 
should be directed at identifying the primary binding sites of ANG in-vivo. In order to establish a 
precise signaling cascade for ANG’s anti-inflammatory actions, phosphoproteomics using 
SILAC (stable-isotope labelling with amino-acids in cell culture) and functional assays for 
neutrophil migration and actin dynamics in specific knock-outs for ANG’s putative binding 
proteins would be conclusive. 
 Based upon my intravital cremaster muscle experiments, it is likely that ANG is acting 
through endothelial cells to inhibit leukocyte adherence and emigration. As v3 integrin and 
angiomotin are expressed on endothelial cells that are the binding sites established in 
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angiogenesis models, it would be interesting to see if conditional 3 or angiomotin knockout 
mice show an increased neutrophil recruitment upon TNFα activation. 
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